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·- ·SUMMARY 
1. The proteinase inhibitor Trasylol was shown to be unable to 
reduce the formation of granulation tissue and the development of 
inflammation in rats with adjuvant induced arthritis. In contrast 
Trasylol clearly inhibited the proteinases found in human 
rheumatic synovial fluid samples which are responsible for tissue 
dama~e. 
2. It was confirmed that alpha-2-macroglobulin and .proteinase levels 
are related to the total protein · content of human rheumatic synovial 
fluid. In addition, a relationship between proteinase and alpha-1-
antitrypsin was established. 
3. Bacterial endotoxin was shown to be_ anti-inflammatory when given 
intraperitoneally and not irritant. When incubated with macrophages 
the endotoxin was· lytic. It also contained small amounts of 
oligoamines. 
4. Putrescine was proven to be a potent anti-inflammatory agent as 
was spermidine, while spermine and cadaverine had little or no 
activity. These activities were not related to ·the irritancy of the 
compounds and none of the oligoamines had any effect on the 
development of a local anaphylactic reaction _in the mouse ear. Both 
putrescine and cadaverine were capable of stabilizing the membranes 
of macrophages in ·vitro while spermine and spermidine were _lytic 
towards them. In addition putrescine inhibited the development of 
adjuvant induced arthritis in the rat. Drugs which increased the 
levels of putrescine were also anti-inflammatory. 
5. Human rheumatic synovial fluid was found to contain two or more 
substances which were anti-inflammatory, but irritant. Fractions of 
the synovial fluid also stabilized the membranes of macrophages. 
6. Fractions of liver extracts from DMNO treated rats were anti-
inflammatory and this was related to their irritancy. It was shown 
that the high molecular weight fraction degraded both in ·vitro 
and in vivo pr oducing dialysable molecules which were anti-
inflammatory. Putrescine and cadaverine were greatly elevated .by 
DMNO treatment and may explain these results. 
7. Inflammatory exudate produced by the implantation of polyester 
sponge stabilized the membranes of macropha_ges as did the two 
fractions produced by gel filtration·. Sponge exudate was shown to 
possess inherent proteolytic activity which caused the breakdown of 
the exudate both in vitro and ·in •vivo releasing dialysable molecules 
which had an anti-inflammatory effect. Sponge exudate both contains 
and is capable of releasing oligoamines which have been shown to be 
directly anti-inflammatory and may, at least in part, account for the 
activity exhibited by the exudate. 
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1. INTRODUCTION 
Inflammation is the process by which living tissue responds 
to injury. In many instances it is trivial, such as with an insect 
sting, but sometimes it can be a serious and even life threatening 
condition. In man the most prevalent inflammatory conditions are 
known collectively as the rheumatic diseases. This classification 
covers a wide variety of syndromes and includes diseases associated 
with high mortality such as Systemic Lupus Erythematosus (SLE) and 
diseases such as rheumatoid arthritis and osteoarthrosis which are 
severely crippling, but are not usually life threatening. 
Both of these crippling diseases are prevalent,but 
rheumatoid arthritis can be more serious since severe forms of the 
disease can quickly lead to loss of mobility. Osteoarthrosis is not 
a well defined disease,' but may be considered to be largely a "wear 
and tear" disease that represents a gradual loss of function of 
joints as part of the aging process. Due to the serious nature of 
rheumatoid arthritis it has received great attention from research 
workers. 
The researcher into rheumatoid arthritis must accept the 
discouraging statement that the syndrome is of largely unknown 
cause and aetiology and, in addition, there is no known cure. 
It is for these reasons that many researchers assume that 
a study of inflammation will help our understanding of rheumatoid 
arthritis, and much of modern drug therapy is based on this belief. 
It is certain that inflammation plays a large part in the disease and 
the work described in this study has been concerned with controlling 
inflammation as a means to treat rheumatoid arthritis. 
1.1 The Nature of Inflammatory Stimuli 
The stimulus giving rise to inflammation may be one of 
1 
several factors, but trauma of one type or another is a coJDJDOn 
feature. 
The ability of a drug or chemical substance to provoke 
an inflammatory response is ter.med irritancy. In this case the 
tissue damage may be restricted to the site of administration and is 
not usually severe, although some irritants, for example: croton 
oil or corrosive poisons, are very potent and may cause severe 
and prolonged inflanunation. 
Inflammation may also develop due to infection, the tissue 
damage being caused by toxins or the organisms themselves. The 
response may be a consequence of activity of the immune system to the 
infectious organism (Hicks, 1975). Several organisms have been 
implicated in the search for an •infectious agent in rheumatoid 
arthritis. Marmion (1976) concluded that there was no evidence that 
diptheroids, mycoplasmas or other prokaryotes were the missing 
exogenous antigens in rheumatoid arthritis, but there were some 
preliminary hints that a defective rubella, or other, unidentified 
virus may be involved. 
In addditon, inflarnmation,both mild and severe, may be 
the consequence of an allergi~ malfunction of the immune system as 
typified by rheumatoid and other "autoimmune"diseases. 
1.2 The ·Inflammatory Process 
Inflammation involves change in the connective tissues 
and vascular supply of damaged tissue. The process may be considered 
as a protective measure, designed to minimise or eliminate the cause 
of damage and subsequently to remove the damaged tissue and lead to 
its repair. The acute inflammation following a sti~ulus involves 
two components, fluid and cellular,both arising from a v~scular source. 
The first changes are a brief arteriolar constriction 
foll owed by prolonged dilation of .arterioles, capillaries and venules 
after the stimulus is received (Spector and Willoughby, 1968) . 
., 
This process is accompanied by an increased permeability of the venules 
and capillaries (Cotran, 1967) with a consequent loss of fluid into 
the surrounding tissue. 
The increase in permeability of blood vessels to plasma 
protein following injury is now known to have a biphasic nature. The 
initial phase, which has not been shown for all experimental 
i nflammations, has a transient character and primarily involves the 
venules, whereas the delayed or prolonged phase of increased 
permeability involves the capillaries as well (Cotran, 1967). 
However, in certain inflammations the venules appear to be solely 
r esponsible for the delayed phase (Hurley and Spector, 1965). 
In general, the initial phase of this response can be 
inhibited by antagonists of known endogenous permeability factors 
(Logan and Wilhelm, 1966). Histamine is a likely candidate as a 
mediator of this increased vascular permeability and considerable 
evidence is available to support this view. For example, histamine 
has been found in the exudate after intrapleural injection of 
turpentine for up to thirty minutes after initiation of the pleurisy 
(Spector and Willoughby, 1957). Venule labelling with colloidal 
carbon can be inhibited by anti-histamine treatment during this 
initial phase (Hurley and Spector, 1965) and, also, tissue depletion 
of histamine has been shown to delay the onset of inflammation 
produced by injection of bacteria (Sheldon and Bauer, 1960). Thus 
histamine ap~ears to be the major mediator in this phase of increased 
vascular permeability although it plays no part in the prolonged 
phase of the response (Spector and Willoughby, 1968). In rats and 
mice 5-hydroxytryptamine is thought to have a role in addition to 
histamine, but this fact seems peculiar to these species. 
In the prolonged phase many mediators may be involved in 
the response, but in the case of the ca~rageenan induced oedema in 
3 
the rat (Di Rosa and Willoughby, 1971; Di Rosa, Giroud and 
Willoughby, 1971) kininlike substances are thought to maintain the 
oedema during its plateau phase and prostaglandinlike substances 
promote the second accelerating phase of swelling, both these 
events occurring after the initiation of the response by histamine 
and 5-hydroxytryptamine. The involvement of kininlike substances 
is suggested by work which shows an inhib_ition of the oedema by 
antiprat:einases (Von Arman, Begany, Miller and Pless, 1965; Di Rosa 
and Sorrentino, 1968) . Briseid, Arntzen and Dyrud (1971) have 
correlated changes in the plasma kinin system with inhibition of the 
oedema, other work has also supported this involvement of kinins 
(Di Rosa, Giroud, and Willoughby, 1971; Vinegar, Macklin, Truax, and 
6elph, 1971). Prostaglandin-like substances have been implicated in 
the second phase of the oedematous response (Di Rosa and Willoughby, 
1971) and the isolation of E-type prostaglandins from oedema fluid 
has been claimed although artifacts may be present in this case (Willis, 
1969). Chang, Murota and Tsurufugi (1976) concluded that E-type 
prostaglandins, at best, have a minor role as mediators of vascular 
permeability. However, it is now known that many of the non-steroidal 
anti-inflammatory drugs inhibit prostaglandin synthesis which is 
thought to be their mode of action and, indeed, the ability of these 
compounds to inhibit prostaglandin synthesis seems to parallel 
their therapeutic efficacy (Vane, 1971; Paulus and Whitehouse, 1973). 
Recently, leukotriene B, a product of the lipoxygenase pathway of 
arachidonic acid metabolism, has been found to increase vascular 
permeability in the presence of a vasodilator such as PGE2. (Bray, 
Cunningham, Ford-Hutchinson and Smith,1980). 
These changes in the vascular channels together with the 
altered permeability cause an increase in viscosity of the blood 
which is responsible for pushing the leukocytes against the vascular 
4 
endothelium to which they adhere and eventually migrate into the 
extravascular tissues. 
The cellular component of ~n acute inflammatory exudate 
is now thought to be of haematogenous origin, as opposed to local 
proliferation of histiocytes and reticule-endothelial cells (Spector, 
Walters, and Willoughby, 1965). For most experimentally induced 
inflammations, it has been found that the polymorphonuclear 
leucocytes are the first cells to enter the injured area, but, with 
time, the mononuclear cells (monocytes, lymphocytes, and plasma 
cells) predominate (Martin and Southwell, 1965; Hurley, Ryan and 
Friedman, 1966; Ryan, 1967). These results conflicted with the 
earlier work of Spector, Walters and Willoughby (1965) and Spector 
and Coote (1965) who found mononuclear cells emigrating concurrently 
with the polymorphonuclear leucocytes, though in far smaller numbers. 
The emigration of cells from small blood vessels is now 
well documented, largely from electron microscope studies, and reveals 
that, after injury, leucocytes adhere to the vascular wall and emigrate 
across the endothelium by extending pseudopodia between the endothel-
ial cells. The emigration of leucocytes appears to be divorced 
from th~ leakage of protein and indeed emigration can take place 
with little or no permeability increases . 
The various types of inflammatory cells proceed to remove 
the foreign material and to demolish the severely damaged tissue 
prior to repair. Polymorphonuclear (PMN) leucocytes play a key 
role in this phase of the process. During the process of phagocytosis 
these cells release a number of biological molecules (Weissmann, 
Smolen and Hoffstein, 1978). For example derivatives of molecular 
oxygen (o2· ,oH· and H202) which have a bactericidal action, 
inflammatory mediators such as prostaglandins and thromboxanes are 
also released. The PMN leukocyte also secretes lysosomal proteinases 
5 
which aid tissue demolition. 
The process of repair may now take place with the 
development of granulation tissue. The tissue is reformed by 
fibroblast cells which migrate from surrounding connective tissue 
and deposit collagen fibres around the lesion . If at this point 
the inflammatory stimulus still persists, macrophages often undergo 
a proc;ess of fusion, giving very large multinucleate "giant cells" 
which attempt to surround the stimulus·. Ultimately persistent 
inflammatory sites may become calcified. 
The development of inflammation is summarised in the 
following diagram:-






~ ~ Tissue Demolition 
! 
Repair ~---------------- Granulation, fibrosis 
! - - - - - -
Calcification 
---<fr------------------Chronic inflammation 
Giant cell formation 
(After Hicks, 1975) 
1. 3 The U .se of D.rugs in Inflammation 
In order to evaluate the importance of endogenous anti-
inflammatory substances it is necessary to consider the drugs 
currently being used to treat inflammation and some of the problems 
associated with them. 
The drugs in current use may be conveniently split up 
into five groups; antimalarials , gold salts, nonsteroidal anti-
in_flammatory drugs, immunosuppressi ves and immunostimulants. None 
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of these drugs eliminate the cause of the disease (Mathies, 1979) 
but they can alleviate the symptoms. 
In general the five groups of drugs provoke common side 
effects due to the same pathological processes occurring. These side 
effects are commonly immunological in nature due to either the immuno-
logical effects of the compounds or of the immunogenicity acquired 
by the compounds upon their formation of complexes with proteins 
or platelets (Franchimont, Heyren and Hanvwaert, 1978). The side 
effects may include skin rashes, leukopenia, glomerulonephritis and 
symptoms comparable with those found in viral diseases (fever, chills 
etc.). 
Side effects associated with metabolism may be important 
with some drugs, for example, D-penicillamine often leads to taste 
disorders due to its effect on copper metabolism (Franchimont, 
Heyren and Hanvwaert, 1978). One of. the most prevalent side effects 
connected with anti-inflammatory drugs is gastric irritation often 
leading to ulceration. 
It is often the case that the most effective and· powerful 
anti-inflammatory drugs ~re associated with some of the more severe 
side effects seen. 
From this brief review it is clear that all the drugs which 
are currently in use in the treatment of inflammation suffer from the 
disadvantage that their use may cause severe side effects. 
It is for these reasons that endogenous anti-inflamrnator-J 
substances have been the subject of intensive study by experimental 
investigators. An endogenous anti-inflammatory substance would have 
the benefit that it would not be so liable to produce injurious side 
effects and also a study of the organisms natural defence mechanism 
may elucidate the inflammatory process. 
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1.4 Antiproteirtases 
Antiproteinases may be considered to be endogenous anti-
inflammatory substances since they occur naturally and may play a 
role in inflammation. The involvement of lysosomal enzymes (.elastase, 
collagenase, cathepsin G) released by· polymorphonuclear leukocytes 
in inflammation is well known (Weissmann, Smolen and Hoffstein, 1978). 
The overall activity of proteinases is the result of the activity of 
the proteinase and the activity of any proteinase inhibitor present. 
Thus antiproteinases may have a role in inflammation and have been 
extensively studied. 
1.4.1 Al~ha-1-antitrY.ESin 
Alpha-1-antitrypsin was isolated, characterized and named 
by Schultz, Heide and Haupt (1962). Of all the proteinase inhibitors 
alpha-1-antitrypsin has the highest molar concentration in blood 
(40-lOOµmol/L) and is responsible for up to 90% of the trypsin 
inhibiting capacity of plasma (Ganrot, P.O., 1972). This inhibitor 
has been structurally designated as an alpha-1-glycoprotein which is 
composed of a s ingle polypeptide chain having 12% carbohydrate and 
containing galactose , mannose , acetylglucosamine and sialic acid and 
has a molecular weight of between 47,500 and 55,000 daltons (Crawford, 
1973; Musiani and Tomasi, 1976). The protein is heat labile and can 
be irreversibly inactivated at low pH (<5). 
Alpha-1-antitrypsin has been found to inhibit the action 
of a number of serine proteinases beside trypsin, these include: 
chymotrypsin, plasmin, thrombin (Rimon, Shamash and Shapiro, 1966), 
kallikrein (Haberman, 1968), elastase (Kaplan, Kuhn and Pierce, 1973), 
granulocytal elastase (Ohlsson, 1971) and granulocytal collagenase 
(Harris, Di Bona and Krane , 1969), all of which are associated with 
inflammation. It should be noted that alpha-1-antitrypsin does not 
inhibit all collagenases. It does not, for example, inhibit acid 
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proteinases (Kopitar and Lebez, 1975) and also a neutral 
collagenase isolated from human gastric mucosa is unaffected 
(Woolley, Tucker, Green and Evanson, 1976). 
Alpha-1-antitrypsin is a so called acute phase reacting 
(APR) protein which implies that the concentration in plasma 
increases in infection and inflammatory conditions. Patients 
suffering from rheumatoid arthritis show a significant rise in alpha-
1-antitrypsin levels in both serum and synovial fluid. A large 
molecular protein with the immunological specificity of alpha-1-
antitrypsin, presumably a complex of the inhibitor and a proteinase, 
was detected in the synovial fluid of subjects with confirmed or 
suspected rheumatoid arthritis (Brackertz, Hagmann and Kueppers, 
1975). 
The inhibitor can exist in a large number of genetic 
variants of which the so called MM type is the form found in 
normal individuals. A slowly migrating component, called ZZ is seen 
on electrophoresis in cases of genetic deficiency. Cox and Huber 
(1976) claimed an association between heterozygosity for the Z allele 
of alpha-1-antitrypsin and classical rheumatoid arthritis. This 
finding has been disputed by several workers (Sjoblom and Wollheim, 
1977; Brackertz and Kueppers, 1977; Buisseret, Pembrey and Lessof, 
1977) who claim the influence of alpha-1-antitrypsin polymorphism 
on the incidence and course of rheumatoid arthritis is modest at most. 
Lewis and Capstick (1977) claimed to have found an inverse 
relationship between alpha-1-antitrypsin and neutral proteinase 
levels in human rheumatoid synovial fluid. A similar relationship 
was demonstrated in the sera from adjuvant arthritic rats, the alpha-
1-antitrypsin levels falling as the disease progressed (Parrot and 
Lewis, 1977). The levels of plasma alpha-1-antitrypsin are also 
elevated during pregnancy (Fagerhol and Laurell, 1970) and viral 
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hepatitis (Kindmark and Laurel!, 1972) both of which are known to 
produce a remission of rheumatic disease. 
1.4.2 Al£ha-2-macroglobulin 
The second major antiproteinase found in plasma is 
alpha-2-macroglobulin (2.5 - 5 µmol/1) and it accounts for nearly 
10% of the trypsin inhibiting capacity of plasma (Ganrot, P.O. and 
Sch~rsten, 1967). The molecular weight of alpha-2-macroglobulin has 
been estimated to be in the range of 725,000 to 820,000 daltons 
(Schonenberger, Schmidtberger and Schultz, 1958; Roberts, Riesen 
and Hall, 1974), but there is no information regarding its 
quaternary structure. Jones, Creeth and Kekwick (1972) have suggested 
an eight chain subunit structure, with dimers of these chains 
forming the 196,000 dalton subunits produced by limited thiol 
reduction of alpha-2-macroglobulin (Frenoy, Razafimahlaeo and 
Bourrillon, 1972). Four of these subunjts may then form an alpha-
2-macroglobulin molecule. 
Alpha-2-macroglobulin exhibits a wide spectrum of 
activity. It can bind and inhibit proteinases from all groups of 
endopeptidases. These include trypsin, chymotrypsin, plasmin, thrombin, 
kallikrein, granulocytal elastase, granulocytal collagenase, cathepsin, 
B1, cathepsin D, thermolysin and chlostridio peptidase A (Barrett and 
Starkey, 1973). Cathepsin B1and neutral collagenases are known . 
to be capable of attacking the triple helix of collagen (Burleigh, 
1973) and together with cathepsin D of degrading proteoglycans 
(Burleigh, Barrett and Lazarus, 1974). The levels of alpha-2-
macroglobulin are also elevated during pregnancy (Schumacher and 
Schulmberger, 1963) and the protein may be detected in the synovial 
fluid of rheumatoid arthritic patients although it was in the 
inactive form in 25% of the patients. It was, however, active in 
the sera from these subjects. 
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In the rat, alpha-2-macroglobulin does not occur in the 
plasma of normal rats, but certain conditions, for example, foetal 
and neonatal states, pregnancy, neoplastic growth, interference 
with the kidney and inflammation cause it to appear in the plasma 
of such rats ("Heim, 1968). K. Ganrot (1973) has found that this 
alpha-2 acute phase globulin binds plasrnin and trypsin and can be 
considered as a human alpha-2-macroglobulin homologue. In the 
normal rat the function of alpha-2-macroglobulin is performed by 
alpha-1-macroglobulin (Ganrot, K. 1973). 
1.4.3 Other_AntiEroteinases 
A potentially important antiproteinase was discovered by 
vbolley, Roberts and Evanson (1976) in human plasma. Migrating 
electrophoretically as a beta-1-globulin, with a molecular weight 
of about 40,000 daltons, it has been named beta-1-anticollagenase 
since it specifically inhibits neutral collagenases. Its importance 
may lie in the fact that it can inhibit collagenases which are 
normally inhibited by alpha-2-macroglobulin, but its smaller 
molecular size would enable it to reach inflammatory sites much 
rr.ore easily. 
Other proteinases are present in human and animal plasma, 
but since their concentrations are extremely low they may be of less 
importance. However, inter-alpha-trypsin and alpra~l-sntichymotrypsin 
have been found to inhibit trypsin, chymotrypsin and chymo1rypsin respect-
ively (Heide,Heirnbureer and Haupt, 1965;Heirnburger and Haupt, 1965). 
Rat plasma appears to have another antiproteinase in 
addition to alpha-1-antitrypsin, alpha-1-macroglobulin and alpha-2-
acute phase protein. This protein has an approximate molecular 
weight of 90,000 daltons and inhibits trypsin and chymotrypsin, 
but its trypsin inhibitory capacity in plasma is less than that of 
alpha-1-antitrypsin and alpha-1-macroglobulin (Huttunen and Korhonen, 
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1973). 
A subject of recent investigations has been the 
proteinase inhibitor Trasylol (Bayer). Trasylol appears to 
influence many functional systems, these include blood clotting, 
thrombolysis, complement and plasma kinin formation. 
Forster (1969), using a variety of inducing agents showed 
that Trasylol inhibited the formation of rat paw oedema and the 
arthus reaction. The activity of acid and neutral proteinases 
were reduced in the serum of these animals. Spilberg and Kirk-
Osterland (1970) using sodium urate crystals to induce an acute 
arthritis in the rabbit found Trasylol to be anti-inflammatory 
and suggested that Trasylol may act by inhibiting acid and neutral 
polymorphonuclear leukocyte lysosomal proteinases. The evidence 
that Trasylol is beneficial in the treatment of human rheumatoid 
arthritis is contradictory. It has been claimed (Bruckner and 
Eisen, 1970) that Trasylol compares favourably with hydrocortisone 
acetate in the treatment of the disease and may be useful where 
steroids are contra-indicated. In contrast Marcy , Loyan and Dumas 
(1972) found Trasylol to be relatively ineffective in the treatment 
of this condition. 
1 . 5 Endogenous Anti - Inflammatory Substances 
There are many reports in the literature concerning 
inflammatory exudates, but from early work (Rindani, 1956) it 
became clear that anti-inflammatory substances were present in such 
exudates. 
Lyophilized granuloma pouch exudates obtained from intact or 
adrenalectomised rats were found to contain a substance capable of 
inhibiting granulation tissue formation (Dispasquale and Girerd, 
1961) . The activity contained within this exudate was later found 
not to be due to inherent ACTH or adrenal corticoid activity 
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(Dispasquale, Girerd, Beach and Steinetz, 1963). 
Many workers have used in vitro tests for anti-inflammatory 
activity and using such techniques Persellin (1972) found that 
a protein derived from arthritic rat plasma, that migrated 
electrophoretically as an alpha globulin with a molecular weight 
of 170,000 daltons stabilized rat liver lysosomes against thermallysis. 
Human sera has been found to inhibit the lysis of rabbit polymorpho-
nuclear leukocytes by Triton X-100 (Hempel, Fernandez and Persellin, 
1970), this ability, which is not due to increased corticosteriod 
levels, being increased during pregnancy. 
Lewis, Capstick and Cosh (1975) demonstrated that human 
rheumatoid synovial fluid stabilized rat liver lysosomes 'in vitro. 
This stabilizing effect was abolished by pre-incubation of the 
synovial fluid with trypsin. Later work (Lewis, 1977) has shown 
that two proteins were responsible for this effect and they migrate 
in the alpha/beta globulin region during electrophoresis. 
A high molecular weight protein fraction from the sera of 
normal rats was isolated by Lewis, Capstick and Best (1976). This 
fraction was shown to be anti-inflammatory against the carrageenan 
induced oedema and the adjuvant arthritic animal models . 
Antilymphocytic serum was shown to contain two anti-
inflammatory components which could be separated by gel 
filtration (Billingham, Robinson and Gaugas, 1970). One of these 
components was thought to be lgG (75-ij) and the other had similar 
properties to the anti-inflammatory substances found in inflammatory 
exudates. 
One of the few examples of a human inflammatory exudate 
containing an anti-inflammatory substance was provided by 
Billingham, Robinson and Robson (1969b) when they investigated 
the exudate collected from partial gastrectomy patients. It was shown 
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that this exudate inhibited the formation of carrageenan induced 
oedema of the rat foot. In addition, the exudate was fractionated 
using gel filtration, the active component behaving as a macromolecule. 
Bee venom of the honey bee (Apis mellifera) has been found 
to contain a peptide (401) which had a powerful anti-inflammatory 
action, which compared favourably with both steroidal and non-
steroidal drugs (Billingham, Morley, Hanson, Shipolini and Vernon, 
1973; Hanson, Morley and Soria-Herrera, 1974). The amino acid 
sequence for this peptide had been previously established by 
Vernon, Hanson and Brimblecombe (1969). In addition to being a potent 
mast cell degranulating factor this peptide was shown to have a 
vascular effect in that it suppresses the increased vascular 
permeability caused by the intradermal injection of smooth muscle 
spasmogens histamine, bradykinin, 5-hydroxytryptophan and prosta-
glandins (Hanson, Morley and Soria-Herrera, 1974). These workers 
concluded that the peptide may make the vascular endothelium anergic 
to phlogistic stimuli. It has been reported recently (Chang and 
Bliven, 1979) that bee venom may have an immunosuppressive effect. 
These workers found that a daily subcutaneous dose of bee venom 
inhibited the formation of adjuvant induced arthritis in the rat. 
This effect was found to be dose dependant. In addition a single 
dose of bee venom given at the same time as the adjuvant or, one 
day after it, suppressed the development of the arthritis by as much 
as 50%. It was suggested that the bee venom may operate by one 
of two mechanisms. Firstly the venom caused an alteration of the 
immune response possible by antigen competition. Secondly the venom 
operated via endogenous corticosteroids. It was concluded that 
the immunological role was probably more important. 
It was proposed by McArthur, Dawkins, Smith and 
Hamilton (1971) that human serum contained peptide like substances 
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in protein bound and free forms. It was suggested that 
abnormally low concentrations of the free forms were an important 
factor in the development of rheumatic diseases. A peptide-like 
substance which possessed anti-inflammatory activity and was 
capable of binding to circulating proteins was isolated from human 
serum by McArthur, Smith and Freeman (1972). 
Using an improved isolation procedure the substance was 
shown to exhibit no antagonistic effects towards the inflammatory 
mediators histamine, 5-hydroxytryptamine, bradykinin and prosta-
glandins E2 and F2« when tested on isolated tissue preparations 
(Elliot, Ford-Hutchinson, Harford, Insley, Smith and Sturgess, 1973). 
Further work has shown that this substance had an apparent molecular 
weight of below 1000 daltons, could be partially purified by solvent 
extraction and was resistant to acid and proteolytic digestion. This 
plasma fraction exhibits a broad spectrum of anti-inflammatory 
activity ranging from inhibitior; of oedema formation to reduction 
of the infiltration of leucocytes into inflammatory exudates (Smith 
and Ford-Hutchinson, 1975). It was concluded this fraction must be 
considered as a specific anti-inflammatory substance and its possible 
mode of action was on the release of chemotactic factors after the 
activation of the complement cascade. 
The ameliorating effect of hepatic disease on rheumatoid 
arthritis has been known for some time (Hench, 1933) and although 
jaundice was thought to be the determining factor in these 
remissions a satisfactory explanation has never been offered (Hill 
and Holley, 1966). 
Pinals (1973) induced hepatic damage in rats using intra-
peritoneal injections of the selective hepatotoxin dimethylnitrosamine. 
He found that adjuvant arthritis of the rat was partially inhibited 
by the administration of dimethylnitrosamine on the fourth or fifth 
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day after the injection of the mycobacterial adjuvant. Furthermore, 
saline extracts of livers from dimethylnitrosamine treated rats 
were capable of inhibiting the development of adjuvant arthritis, 
whereas saline extracts from normal rat livers were ineffective. 
Finals suggested that some anti-inflammatory material released from 
damaged liver may have been responsible. Lewis, Best, Bird and 
Parrott (1978) have shown that this anti-inflammatory activity is 
contained in the high molecular weight region after Sephadex G-150 
fractionation and proteolytic digestion of this fraction may produce 
a dialysable substance with anti-inflammatory activity. 
The hepatoxin carbon tetrachloride has also been found to 
inhibit the formation of granulation tissue and carrageenan 
induced oedema (Mielenc, Drobeck, -Rozitis and Sansone (1969}. 
One inflammatory exudate which has been extensively 
studied is that produced by the subcutaneous implantation of polyester 
sponges into rats. This exudate has been shown to inhibit the 
formation of granulation tissue (.Robinson and Robson, 1964). 
It was suggested that this anti-inflammatory factor was 
not present in normal serum, but may be present in the serum of sponge 
implanted rats. Further work has shown that the exudate retarded 
the rate of wound healing, but did not significantly alter the 
formation of oedema fluid. The active principle was also found to 
be a non-dialysable (Robinson and Robson, 1966). The exudate was 
found to be active in other animal models. It inhibited the 
formation of carrageenan induced oedema of the rat foot and when injected 
subcutaneously intoBCG-vaccinated guinea pigs a significant, though 
transient, supression of tuberculin reactivity in the sk~n was noted 
(Gaugas, Billingham and Rees, 1970). 
Billingham, Robinson and Robson (1969a) demonstrated that 
the exudate could be fractionated by gel filtration and ion exchange 
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chromatography to produce three fractions, two of which were anti-
inflammatory. They further showed that this activity could be 
destroyed by incubation above 70°C or with pronase. The activity 
of the exudate was not due to the presence of steroids since the 
levels in the exudate were lower than in normal serum. The protein/s 
studied in this work were further purified by preparative poly-
acrylamide gel electrophoresis (Billingham, and Robinson, 1972). 
The resultant preparation was claimed to have a high anti-inflammatory 
activity, but to be no more irritant than saline. Later work has 
been concerned with the possible mode of action of this preparaticn, 
but this has met with little positive success. The inflammatory 
exudate inhibited the formation of pleural effusion, emigration of both 
neutrophils and mononuclear cells and the accumulation of p-
glucuronidase and lactic dehydrogenase (Doherty and Robinson, 1976b). 
The same dose of exudate did not, however, inhibit the increased 
vascular permeability induced in rat skin or rat foot following 
injection of 5-hydroxytryptamine, histamine, prostaglandin E1 or 
bradykinin. Furthermore, sponge exudate did not reduce the haemolytic 
complement titre of rat serum either in vitro or in vivo. The 
exudate had no stabilizing effect of lysosomal preparations (Doherty 
and Robinson, 1976a). The origin of the anti-inflammatory factor contained 
within this exudate has been attributed to de novo synthesis by the 
liver following injury to the animal (Billingham, Gordon and 
Robinson, 1971). 
In summary, it appears that polyester sponge induced 
inflammatory exudate contains an anti-inflammatory factor which is 
protein-like, synthesized .de novo by the liver following injury and 
migrates electrophoretically between the alpha-glycoproteins and 
transferrin. Little, however, is known regarding its exact nature 
or mode of action. 
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The mechanism of action of the potent anti-inflammatory 
agent dexamethasone is not yet understood, but it has been found 
that both RNA and protein synthesis appear to be essential for 
the manifestation of the anti-inflammatory effect (Tsurufuji, Sugio, 
and Tekemasa, 1979). It has also been shown that glucocorticoids 
induce the biosynthe5is of a protein (or peptide) inhibitor which 
prevents prost_aglandin generation (Flower and Blackwell, 1979). 
1.6 The Anti-Inflammatory Activity of Irritants 
The relief of inflammation by the use of non-specific 
irritants has been employed by physicians for many centuries. The 
mechanism by which a local irritation exerts an additional more 
remote anti-inflammatory effect is, as yet, an unexplained phenomenon. 
This counter irritant effect is particularly important when 
considering any endogenous anti-inflammatory substance since it 
may be argued that such substances may operate by causing irritation. 
Laden, Blackwell and Fosdick (1958) showed that in rats 
the volume of pleural exudate produced by the injection of an 
irritant (gum arabic) was reduced by a second irritant (gwn arabic 
or silver nitrate) injected into the knee joint. This anti-inflammatory 
effect could not be explained by loss of fluid into the injected knee. 
The intraperitoneal administration of a wide variety of 
agents such as hydrogen peroxide, sodium hydroxide, kaolin and talc 
inhibited the inflammatory oedema of the rat paw induced by formalin, 
dextran, 5-hydroxytryptarnine and polyvinylpyrolidine (Von Buch and 
Wagner-Jauregg, 1960; Von Buch and Wagner-Jauregg, 1962). 
Cygielman and Robson (1963) found that tartar ernetic,croton 
oil and talc caused a significant reduction in the granulation 
tissue deposited around cotton pellets implanted in intact and 
adrenalectcmised rats. They suggested that there was some limit to 
the total number of leukocytes which in the course of a few days 
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could be mobilised to take p~rt in the inflammatory reaction. 
Acetic acid, formaldehyde and hypertonic saline 
inhibited the development of carrageenan induced oedema. This was 
thought to be related to the extravasation of fluid and proteins into 
the peritoneal cavity (Jeri and Bernardi, 1966). 
Atkinson, Boura and Hicks (1969) reported that polyester 
sponge induced inflammatory exudate possessed local irritant 
properties. The sponge exudate was found to increase vascular 
permeability, but its· tonicity was found to be unimportant. Atkinson 
and Hicks (1971) noted that a correlation existed between the anti-
inflammatory and irritant properties of sponge exudate. These results 
were further substantiated using different techniques by Atkinson, 
Whittle and Hicks (1971). The plasma from sponge bearing rats was 
claimed to have no anti-inflammatory activity even when the sponges 
irritancy was augmented by croton oil. These workers (Atkinson and 
Hicks, 1975b) concluded that the induction of inflammatory lesions in 
rats did not appear to lead to a detectable release of endogenous 
anti-inflammatory substances into the circulation. 
The mechanism of counter irritation is unknown, but 
Atkinson and Hicks (1975a) in their review of the subject suggested 
the fol l owing possibil ities . 
Since the administration of an irritant may be considered 
to be a stress stimulus it may be that the resultant pituitary-
adrenal stimulation is of importance. However, since a number of 
reports indicate that irritants have a similar effect on 
adrenalectomized and hypophysectomized rats as normal animals this 
explanation seems unlikely (Laden, Blackwell and Fosdick, 1958; 
Cygi elman and Robson, 1963). 
Another hypothesis is that there may be competition 
between two inflammatory sites for finite quantities of inflammatory 
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mediator(s) or their precursors. Atkinson and Hicks (1975a) 
conclude that this mechanism may be important in acute conditions 
with finite concentrations of mediator material like the kinin or 
complement systems. However, competition for cellular and other 
mediators seems less likely, presumably because given time the 
system is capable of producing very large numbers of cells and 
possibly restoring the availability of other mediators. 
A possible mechanism which has received much attention is 
the production and/or release of endogenous anti-inflammatory 
substances at the site of inflammation. These substances could then 
enter the blood stream and produce an inhibition of inflammation 
at a r~mot·e site . The evidence supporting this theory comes from a 
demonstration of anti-inflammatory substances found at inflammatory 
sites (See Section 1.5) and of anti-inflarranatory activity in the 
blood of animals bearing inflammatory sites. Support for the latter 
phenomenon has come in part from a study of acute phase reactants. 
Bogden , Gray and Fuss (1966) while working with alpha-2-glycoprotein 
found that serum from traumatized animals caused increased alpha-
2-glycoprotein synthesis in normal rats. Plasma and serum obtained 
from rats four days after implantation (s .c.) of polyester sponges 
has been shown to exert an anti-inflammatory effect (.Robinson and 
Robson, 1964i Billingham, Robinson and Robson, 1969a). These workers 
have suggested that this anti-inflammatory factor is synthesized by 
the liver , and indeed, perfused livers from traumatized rats did 
produce an anti-inflammatory factor (Billingham, Gordon and Robinson, 
1971). 
The presence of a factor in the plasma of such rats has 
recently been disputed by Atkinson and Hicks (1975b) who found no 
evidence of anti-inflammatory activity in their plasma. Atkinson 
and Hicks (1975a) concluded that no one theory is acceptable. 
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Rather, it would appear that a variety of mechaniSlDS are evoked by 
different irritants or inflammatory states . 
1.7 The Role of Endotoxins in the Study of Endogenous Anti-
Inflamniatory Agents 
Recently it was concluded that doubt will exist about the 
presence of anti-inflammatory factors in mammalian body fluids 
unless ~tringent precautions are taken to exclude measurable bacterial 
contamination (Maguire and Wallis, 1977). These workers were 
investigating the anti-inflammatory properties of anti-lymphocytic 
serum, which had previously been discovered by Billingham, Robinson 
and Gaugas (1970). Gel filtration of non-sterile anti-lymphocytic 
serum yielded two fractions showing anti-inflammatory activity. 
One fraction elut2d with an apparent molecular weight of 200 ,000 
while the other eluted with the serum salts(~ 5000) which upon 
rechromatography behaved as a high molecular weight material. This 
fraction was contaminated with gram negative bacteria. Sterile anti-
lymphocytic serum when chromatographed had only one active fraction 
(high molecular weight), the lower molecular weight fraction had 
no detectable anti-inflammatory effect. Bacterial preparations 
from the non-sterile serum and commercial endotoxin were markedly 
anti-inflammatory. This lower molecular weight fraction was 
capable of elevating 11-hydroxycorticosteroid levels and abolishing 
leukocyte infiltration into the foot injected with irritant, but 
the serum haemolytic complement levels and the total number of 
circulating leucocytes were unchanged. 
Furth.er evidence concerning the anti-inflammatory role of 
endotoxin was provided by Smith, Ford-Hutchinson and Walker (1977). 
These workers found that endotoxin inhibited carrageenan induced foot 
oedema and reduced the total l eucocytes found in an exudate caused 
by polyester sponge implantation. 
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This endotoxin preparation did not cause a local 
irritant action when injected in the foot pad of rats . These workers 
also investigated the connection between endotoxin and an anti-
inflammatory fraction derived from human plasma (Ford-Hutchinson, 
Insley, Elliot-, Sturgess and Smith, 1973). It was found that part 
of the overall anti-inflammatory activity was due to the presence 
of material resembling endotoxin. A low molecular weight fraction 
was also present which possessed properties antagonistic to those 
of endotoxin. 
Endotoxins possess a large number of biological activities 
some of which are inflammatory. The well known Shwartzman reaction 
has been described as a model of inflammation (Rosenthale, 1974) . 
Endotoxin has been shown to activate the pat hways of complement 
(Kane, May and Frank, 1973) causing changes in vascular permeability 
and in neutrophil chemotaxis (Mergenhagen, Snyderman, Gewurz and 
Shin, 1969). There is an increased release of vasoactive substances, 
including histamine and the kinins, which may be mediated, at least 
in part, by activated components of The complement system (Hinshaw, 
Brake and Emerson, 1965). In contrast it has been reported (.Conti, 
Cluff and Scheder, 1961) that non lethal doses of endotoxin inhibited 
leucocyte infiltration into areas of rabbit skin infected with 
staphylococci. 
A recent study (Goodman, Way ~d Irwin, 1979) has shown that 
the intravenous injection of endotoxin has marked effects. Doses of 
50-100 µg per Kg evoked a marked inflammatory response. Within ten 
minutes there was a decrease in both leucocyte and platelet count . 
that destruction of leucocytes persisted for several It was suggested 
hours after the injectiGn. 
Observation of the vasculature in the 
11 stuck to the endothelium leading to rabbit's ear showed that ce s 
the blood vessels wi·~hin one hour. occlusion of 
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Thus endotoxin has conflicting properties and its role 
is unclear. 
l.B The Role of Ologoamines in Inflammation 
Oligoamines are synthesized in animal and bacterial cells. 
The oligoamines, whose trivial names are putrescine, cadaverine, 
spermine and spermidine, are structurally simple cationic compounds 
which may be involved in a number of processes. Oligoamines are 
intimately involved in cell proliferation mechanisms and may have 
other effects. 
1.8.1 Oligoamines_and_Inflammatio~ 
At the present time the evidence for a direct involvement 
of oligoamines is limited. 
The anti-inflammatory effects of dexamethasone have been 
shown to be mediated by polypeptides synthesized following binding 
of the steroid to the glucocorticoid r-eceptor and induction of gene 
expression (Tsurufuji, Sugio and Takemasa, 1979). Bartholeyns, 
Fozard and P~akash (1980) suggested that the diamine purtescine was 
necessary for the biosynthesis of these anti-inflammatory mediators . 
These workers found that dexamethasone induce:3rises in hepatic 
ornithine decarboxylase activity (the enzyme responsible for the 
synthesis of putrescine) and putrescine concentration which was 
maximal at four hours. The concentrations of spermidine and spermine 
were unchanged. 
Using an irreversible inhibitor of ornithine decarboxylase 
(«-difluoromethylornithine) the effects of dexamethasone could be 
inhibited, but the effects of indomethacin were unaltered. Thus 
these investigators concluded that de ·novO_ synthesis of putrescine 
l.·n the induction of new protein synthesis was an essential factor 
l.
• n the anti -inflammatory action of dexametJ-.asone. 
known to be involved 
This study was extended by Batholeyns • Fozard and Prakash 
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(1981) who found that pretreatment with aminoguanidine sulphate , 
an inhibitor of putrescine catabolism sixteen hours before the 
administration of «-difluoromethylornithine or actinomycin D, 
completely prevented blockade of the anti-inflammatory effect of 
dexamethasone PY · «- difluoromethylornithine but left unaltered 
the suppressive effects of actinornycin D. The de novo synthesis 
was thought to act at the transcriptional level. 
The oligoamine levels in the serum from patients suffering 
from rheumatoid arthritis have been determined by Partsch, Desser 
and Tausch (1978). There was no significant differences between 
normal serum and serum from rheumatoid arthritis patients. 
1.8.2 The_Biosynthesis_of_Oligoamines 
The biosynthetic pathway for oligoamines (collective 
name for di-; tri-; and tetra-, amines) is outlined in the figure 
b elow. 
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Although the figure is self explanatory, there are several 
features worthy of note. The pathway illustrated is only applicable 
to eukaryotes. The main differences between the eukaryotes and 
prokaryates pathway a:>e 1he :ads that prokaryotes have an additional 
route to putrescine from arginine, prokaryote S-adenosylmethionine 
decarbosylases (SAMD) require magnesium ions for activity, but are 
not activated by putrescine and prokaryotes seem generally 
incapable of spermine biosynthesis. 
The n-propylamine group of spermidine and spermine arises 
from methionine. This is an essential amino acid in higher animals 
whereas it is synthesized from aspartic acid in plants and microbes. 
The rate limiting steps in the biosynthetic pathway of 
of oli goamines are generally considered to be orni thine decarboxylase 
(ODC) and SAMD. 
Ornithine decarboxylase has a molecular weight of 55,000 
daltons (Obenrader and Prouty, 1977) and plays a central role in 
differentiation and growth regulation. The enzyme is inhibited 
by various ornithine analogues and requires the presence of thiol 
groups (Ono, Inoue, Suzuki and Takeda, 1972) and pyridoxal phosphate 
as a co-factor. 
ODC has the shortest half life of any known enzyme in 
eukaryotes varying from 15 to 45 minutes (Russell and Snyder, 1969). 
The half life of the enzyme varies during the cell cycle being 
maximal when the growth rate increases (Hogan and Murden, 1974). 
The activity of this enzyme is elevated in r~pidly growing 
organs and in tumour cells (Russell and Snyder, 1969); Williams-
Ashman, Coppoc and Weber, 1972) and the activity also rises as a 
result of the administration of various drugs and hormones (Bachrach, 
1975; Richman, Underwood, Van Wyk and Voina, 1971). 
In addition to hormones, cyclic nucleotides or dibutyryl 
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cyclic AMP stimulated ODC activity in different organs and cells 
in tissue cultures (Bachrach, 1980). It has been suggested that 
cyclic nucleotides mediate ODC induction (Russell, Byus and Manen, 
1976). It was proposed that ODC, and the products of its action, 
the oligoamines, might be the link between hormo~1es, cyclic AMP 
and RNA and protein biosynthesis. This is summarised as shown in the 
following diagram:-
Trophic hormones 
Drugs that induce enzymes ______ .:;i. 
Activation of adenylate 
cyclase Cpfceptore) 
Mitogens 
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rise in ribosomal RNA 
rise in protein 
This mechanism was suggested on the basis of the results from 
several workers and although there is some conflicting evidence, 
for example, treatment of rats with ACTH caused an increase in adrenal 
cyclic AMP without changing ODC activity (Levine, Leaming and 
Raskin, 1978) the argument remains a powerful one. 
One of the most outstanding acl.vances in the study of ODC 
regulation has been the recent demonstration of ODC antizyme 
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(Canellakis, Heller, Kyriakidis and Chen, 1978), 
This ODC antizyme, which. had a 1DOlecular weight of 
26,500 daltons and could be induced by exposing cells to oligoamines, 
reacted specifically with ODC, neutralized its activity and had a 
relatively short half life. It has recently been postulated that 
one antizyme is normally attached to subcellular components (nucleus 
and ribosomes) and that oligoamines at millimolar concentrations 
cause its release (Heller, Kyriakidis, Fong and Canellakis, 1977). 
Oligoamines may thereby regulate ODC activity and control additional 
biosynthesis. 
Purified SAMD from lactating mouse manunary gland was:lound 
to have a molecular weight of between 50,000 and 52,000 (Oka, 
Kono and Perry, 1978). This enzyme was stimulated markedly by 
putrescine which also protected the enzyme against inactivation. 
In contrast spermine inhibited the activity of the enzyme while 
spermidine had no effect. The hormones insulin and hydrocortisone 
were found to increase SAMD activity. 
1.8.3 ProEerties_of_ODC_and_Oligoamines_and_their_Possible 
Relevance to Inflammation 
Although no connection between ODC, oligoamines and 
inflammation is tenuous several properties attributed to ODC and 
oligoamines may be relevant. 
It has previously been described that liver disease has 
an ameliorating effect on inflammation (Hench, 1933). ODC and 
oligoamines have a considerable role in liver damage. Janne and 
Raina (J.968) observed that after partial hepatectomy there was a 
marked stimulation of ODC activity which resulted in a rapid accumulation 
of endogenous 
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putrescine. This increase in putrescine favours an increase in 
spermidine since putrescine acts as a substrate in the spermidine 
synthase reaction and stimulates SAMO, but competitively inhibits 
spermine synthesis (Hannonen, Raina and Janne, 1972; Janne, Paso 
and Raina, 1978). 
The administration of the hepatotoxin carbon tetrachloride 
which has been found to inhibit inflammation (Mielens, Drobeck, 
Rozitis and Sansone, 1969) also causes a marked activation of oligo-
amine synthesis (Holtta, Sinervirta and Janne, 1973). These workers 
also made the observation that during early liver regeneration and 
after carbon tetrachloride treatment there was a conversion of 
spermidine to putrescine. This conversion was suggested to occur 
due to the action of the enzyme peroxisomal polyarnine oxidase in the 
liver. 
The stimulation of ODC was also found to be due to 
various other treatments. It was found that infusions of hypertonic 
glucose or mannitol stimulated ODC and DNA labelling while 3.6% w/v 
saline had no effect. In addition the intraperitoneal injection of 
celite, a chemically inert mechanical irritant, caused a fifty 
fold increase in ODC after four hours. (Schrock, Oakman and 
Bucher, 1970). 
Oligoamine synthesis during the formation of granulation 
tissue induced experimentally by implanting viscose cellulose sponges 
subcutaneously in the rat has been $tudied by Raina, Janne, Hannonen, 
Holtta and Ahonen (1973). It was found that the activities 0£ the 
oligoamine synthesizing enzymes rose steadily during the period of 
rapid cell proliferation an increase in RNA was also noted. A 
rapid increase in ODC activity and accumulation of RNA and oligo-
amines, notably sperrnidine has also been demonstrated in healing 
wounds of rat skin (Mizutani, Inoue and Takeda, 1974). 
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Pregnancy, which is known to cause remissions in 
rheumatic diseases, (Fagerhol and Laurell , 1970) is also known to 
alter oligoamine levels. In both the human and rat the levels of 
oligoamines are elevated during pregnancy. It is notable that in 
the rat the el~vation of putrescine is greatest and spermine shows 
very little change (Andersson,Henningsson and Rosengren, 1978; 
Russell, Giles, Christian, and Cambell, 1978). 
Prostaglandins which are thought to be involved in the 
inflammatory process (Ferreira and Vane, 1974) «lso effect 0DC 
levels. Verma and Boutwell (1980) while studying the mechanism of 
skin tumour promotion by TPA (12-0-tetrdecanoyl phorbol-13-acetate) 
found that prostaglandins may play an important role in the induction 
of 0DC activity. Thjs induction of 0DC activity could be depressed 
by prior treatment with prostaglandin synthetase inhibitors and 
this inhibition could be counteracted by treatment with PGE1 or PGE2 
but not with PGFl« or PGF2«. 
1.9 Animal Models Used in the Investigation of the Inflammatory 
·Process 
Animal models can be useful in the study of inflammation 
and the screening of potential anti-inflammatory agents. It is 
necessary, however, to have some understanding of the underlying 
mechanisms of the models if any conclusi0ns are to be drawn about 
the test substances. 
Satisfactory animal models for most of the rheumatoid 
diseases are not available, but as Swingle (1974) points out in 
his excellent review on the subject, animal models are available 
for different facets of the inflammatory process. Swingle grouped 
these models into four categories according to the criterion for 
activity: 
1. an interference with the manifestation of one of 
~ 
the cardinal signs of the inflammation (swelling, 
redness, heat, pain and loss of function). 
2. the modification of one of the events occurring 
during the inflammatory process (formation of 
granulation tissue, chernotactic assays in vitro) 
3. a biological or chemical characteristic of a class 
of known anti-inflammatory drugs (inhibition of platelet 
aggregation in vitro) 
4. the modification of those syndromes in laboratory 
animals which are believed to represent models for 
various rheumatoid disease states (.adjuvant arthritic 
rat, immune synovitis in the rabbit). 
Successful screening programmes can now be designed for 
potential anti-inflammatory agents. Some models have become more 
acceptable than others because of their simplicity, economic 
feasibility and ability to detect known anti-inflammatory drugs. 
One of the most popular animal models is the carrageenan 
induced rats paw oedema originally described by Winter, Risley and 
Nuss (1962). Swingle (1974) in a study of United States Patents, 
estimated that 66% of the anti-inflammatory tests carried out used 
this model. Carrageenan is a r.iixture of poly~accharides composed of 
sulphated galactose units and is derived from Irish sda moss CSmi th, 
O'Neill and Perlin, 1955). The test is usually conducted by injecting 
the carrageenan into the rats hind foot pad and measuring the size 
of the resultant oedema and comparing this to similar groups of rats 
that have received drugs as well as the c~rrageenan. The development 
of the oedema is considered to be a biphasic event (.Vinegar, Shcreiber 
and Hugo, 1969) with the initial phase attributed to the release of 
histamine and 5-hydroxytryptamine (5-HT); the plateau phase to 
kininlike substances; and the second accelerating phase to the release 
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prost~glanding like substances (Di Rosa and Willoughby, 1971; 
Di Rosa, Giraud and Willoughby 1971) . This model falls into the 
first category in that one of the cardinal signs of inflammation 
is being studied. 
Another widely used model is the polyarthritis induced 
in the rat by the injection of Freundscomplete arljuvant into the 
animals tail or hind f oot pad (Pearson , 1956). The course of the 
disease, which is most easily followed by the daily measurement of 
the rats hind foot volumes , has been described by Pearson and Wood 
(1959). If the hind foot pad is chosen as the site for injection 
of the adjuvant the foot swells immediately with a partial subsidence 
of this swelling about four days after injection . A secondary phase 
swelling occurs nine to twelve days after injection and this is the 
expression of the systemic nature of the disease. Recently some 
work has shown (Liyanage, Currey and Vernon-Robers, 1975) that the 
severity of the arthritis is dependant on the size of the mycobacterial 
particles. Further investigation (Vernon-Roberts, Liyanage· and Currey, 
1976) has shown that there is a rapid and wide-spread dissemination 
of the mycobacter,ial particles. Of particular interest is the 
identification of intact and fragmented tubercle bacilli in the 
synovial lining cells of joints distant from the injection site . 
The synovial tissue of the affected joints proliferates and pannus 
tissue invades the joint space causing severe bone erosion , inflammatory 
cells, such as mononuclear cells are also present in the synovium 
(Pearson and Wood, 1963; Pearson, 1963). This syndrome induced in 
rats has been described as " ... the best available model of rheumatoid 
arthritis" (Walz, DiMartino and Misher, 1971) and" ... the nearest 
experimental apprvximation to rheumatoid arthritis" (Glenn and Kooyers , 
1966) and indeed there are many similarities between it and the 
human condition. However , in this rat disease rheumatoid factor is 
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not present (Glenn, Gray and Kooyers , 1965) and also there are 
few polymorphonuclear leucocytes present at the affected joints 
(Pearson, 1963). 
Granulation tissue is produced during the repair phase of 
the inflammatory process. The repair begins as a proliferation of 
fibroblasts and multiplicati on of small blood vessels by mitoses of 
connective tissue and endot heli al cells . The cellular proliferation 
penetrates the exudate, producing the highly vascularized granulation 
tissue. The model used t o s t udy this sequence of events is the 
cotton wool pellet granuloma test. In this model cotton wool pellets 
of a known weight are implant ed i nto r ats and left for seven days 
after which the animals are sacr i ficed and the pellets recovered and 
dried. The amount of granulation tiss~e can then be measured by 
reweighing the pellet. Swingle and Shideman (1967) have described 
ttree phases o~ the inflammatory r esponse to subcutaneous 
implantation of cotton pellets i n rats . The first phase 
(transudative) occurs during t he f i rst three hours and represents a 
"soaking" of the cotton with fluid of low protein content (a non-
inflammatory transudate). The second phase of the response oGcurred 
between three and seventy-two hours after implantation and was designated 
the exudative phase, which was measured by assessing the amount 
of Evans Blue passing from the circulation to t he implant region . 
The third component of t he response occurred on the fourth 
day after implantation when col l agen was first detected in the 
granulorna also the greatest increase in the number of fibroblasts took 
place between the third and fifth days (Brunkhorst , 1958) . 
Thus, by using the animal models described here , and o~hers , 
it is possibly by using a variety of models to successfully s creen 
out a new anti-inflammatory compound . Since , however , there is no 
true animal model for t he rheumatoid diseas e of man they are of less 
33 
help in an aetiological study of the disease. 
1.10 Aims of Research 
Two approaches were made in this research. In the first 
instance it d 'd was eci ed to investigate the role of plasma anti-
proteinases in the rheumatic diseases since an anti-proteolytic 
action on proteinases r esponsible for joint damage would clearly be 
anti-arthritic. Many drugs used in the treatment of rheuma~ic 
disease are obviously not anti-arthritic , thus a study of the anti-
proteinases may prove beneficial. With this aim in mind the levels 
of va1ious antiproteinases and proteins in human rheumatic synovial 
fluid samples will be studied. It has been shown that the proteinase 
inhibitor Trasylol is effective in acute animal models (Forster, 
1969) and may be useful in the treatment of rheumatoid arthritis . It 
is proposed to study the anti-inflammatory activity of Trasylol in 
some chronic animal models and, using ·irt vitro tests , to investigate 
it~ possible mode of action. 
There is evidence of the existence of endogenous anti-
inflammatory factors that are not anti-proteinases. It was 
decided to probe the identity of these substances further and since 
evidence exists that these factors may be proteins it was decided 
to concentrate on this class of substance. 
for this work the following samples and techniques were 
chosen:-
Both irt vivo 2nd •in •vitro methods will be used to evaluate 
the anti-inflammatory activity of pooled human rheumatoid synovial 
fluid both before and after fractionation by gel filtration . 
The role of liver dam.gem inflammation will be explored 
using liver extracts from animals treated with the hepatotoxin 
dime thy lnitrosamine. This ·extract and fractions derived from it will 
be ev~luated for their anti-inflammatory activity and possible modes 
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of action will be considered. 
The anti-inflammatory effects of the inflammatory 
exudate produced by the subcutaneous implantation of polyester 
sponges are well known, but its mode of action is largely unknown. 
It is proposed to study several possible mo~es of action which 
may be of importance. 
The role of oligcamines in inflammation will also be 
investigated. The relevance of oligcamines to both sponge exudate 
and liver extracts from dimethylni trosamine t:rect:ed rats will be 
studied . In addition the direct anti-inflammatory effects of 
oligoamines will be explored using in vivo and in vitro tests. Drugs 
which are known to promote ODC activity and increase dig-amine 
levels will also be evaluated. 
Finally the role of endotoxin in inflammation and its 
relevance to the pr-=sent work ,.r.ill be investigated. 
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. : 2: :MATERIALS AND METHODS 
2.1.l The 1nduction and Measurement of Adjuvant Arthritis and 
Carrageenan Oedema in the Rat 
Carrageenan oedema was induced in 150-200g male Wistar 
r ats (B3.ntin and Kingman, Hull) by the method of Winter, Risley 
and Nuss (1962). A 2% (w/v) solution of the calcium salt of 
carrageenan (Sigma Chemical Company Limited, U.S.A.) was prepared 
in 0,9% (w/v) sterile saline. A mixture of 3i halothane in oxygen 
(flow rate 300 cc/min) and nitrous oxide (flow rate 1,500 cc/min) 
produced by a Boyles veterinary anaesthetic trolley (British Oxygen 
Company Limited) was used to anaesthetise the rats. The oedema was 
induced by injection of 0. 05 cm3 of the carrageenan solution into 
the plantar aponeurosis of the left hind foot 0f the rat. Control 
animals were injected with 0.9% (w/v) sterile saline. 
Adjuvant arthritis was induced in 150-200g male Wistar 
rats using the method employed by Newbould (1963). The adj"uvant 
consisted of human strains of heat killed C, DT and N tubercle 
bacilli (Ministry of Agriculture Veterinary Laboratories, Weybridge, 
Surrey). The bacilli were finely ground using a glass pestle and 
-3 
mortar and suspended in liquid paraffin at a concentration of 5 mg.cm • 
3 
The rats were anaesthetised, as previously described, and 0.03 cm. 
of the adjuvant suspension was injected into the left hind foot. 
Control animals were injected with O. 9% ( w /v) ·sterile saline. 
The inflammatory response produced by the injection of either 
the adjuvant or carrageenan was estimated by measuring the increase 
in volume uf the hind feet of the rats. The volume of each paw was 
measured plethysmographically using a modification of the method 
described by Harris and Spencer (1962). The hind feet were immersed 
separately, up to the hair line, in a mercury bath which was linked 
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to a blood pressure transducer and an oscillograph recorder 
(Searle Bioscience, Kent). Th e measurements of the hind fee t of 
the rats were taken just prior to the injection of adj uvant or 
carrageenan and again at various intervals during the experiment s. 
2.1.2 Cotton_Wool_Pellet_Granulo~~-!est in the Rat 
--------------
This test for anti-inflammatory activity was carried out 
usihg a modification of the method of Meir, Schuler and Desaulles 
(1950). Cotton wool dental pellets (Johnson and Johnson, England) 
were weighed individually on a torsion balance and only those 
within 0.25 mg. of the mean were used for any one experiment . The 
pellets were then sterilized by autoclaving for 20 minutes at a 
pressure of 15lbs./sq.in. The rats were anaesthetised as previously 
described, and the sterile pellets implanted subcutaneously, one in 
each axilla and groin, giving a total of four pellets per animal. On 
the seventh day after implantation the animals were killed by a blow 
to the head and the pellets dissected out using a pair of forceps. 
The pellets were dried at 60°c for 24 hours and reweighed on the 
torsion balance. The increase in weight of the pellets was used as 
an in~ex of the amount of granulation tissue deposited. Hence, the 
anti-inflammatory effect was calculated as the reduction of the 
increase in weight ·of the cotton wool pellets in the treated groups 
as compared with the untreated control group of animals. 
2·.1. 3 The_ Effect_ of_ Substances_ on_ Pinnal _ AnaEhyla>Sis in_ the_ Mouse_ 
The effect of various substances upon the development of 
a local anaphylactic reaction in the mouse pinna was investigated using 
the method first described by Church, James and Miller (.1974) . 
Male EKW mice (15-20g) were sensitised to horse serum by 
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subcutaneous injection of 0.1 crn. of a 1/20 dilution and 14 days 
later 0.1 cm. 3 of a 1/50 dilution. Six to eight days after the second 
the ml.·ce were taken to a warm room and l hour dose of horse serum 
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later were injected intravenously with 0 , 25 cm. 3 of a o.si (w/v} 
Evans blue solution. 
The test substance was given intraperitoneally 
immediately after the dye soluti'on. F · orty -minutes later the mice 
were challenged by piercing each ear with a hypodermic needle (23 
gauge) which had previously been dipped i nto horse serlDYI to a known 
depth. The area of blueing around the site of challenge was 
measured at 30 minutes and 60 mi'nutes after · · piercing by observation 
through a dissecting microscope, the eyepiece of which had been 
fitted with a measuring graticule. The mice were anaesthetized 
using sodium pentabarbitone (60 mg.Kg.-1 ) for the duration of the 
experiment. 
2 .1.4 Production_of_Inflammatory:_Exudate_Using_Polyester_Seonge 
The method employed was similar to the one used by 
Robinson and Robson (1964 and 1966 ). Recently, Maguire and Wallis 
(1977) working on anti-lymphocytic serum (ALS) suggested that 
bacterial contamination during the collection and subsequent 
fractionation of ALS was responsible for the anti-inflammatory 
activity of the lower molecular weight fractions. 
This findi~g conflicts ·with the earlier work of Billingham, 
Robinson and Gaugas (1970) who attributed the anti-inflammatory 
activity of the low molecular weight fraction to the presence of an 
anti-inflammatory protein. It must be noted that these workers 
took no apparent sterile precautions and , except for sterilization of 
the sponges, neither did Robinson and Robson (1964, 1966). To try 
and resolve these difficulties every effort was made to ensure the 
integri ty of the exudate produced . 
Strips of polyester sponge (F.W. Woolworth and Company} 
25 x 50 x 5 mm. were inserted subcutaneously in the backs of intact, 
adrenalectomised or sham adrenalectomised rats, one piece per rat . 
These acted as the stimulus for exudate formation, and before 
38 
implantation, were sterilized in an oven for two hours at 1so0 c. 
Adrenalectomy was performed on 150-200g, 1 w· ma e 1.star rats which were 
anaesthetised as previously descri"bed. 'The operation area was closely 
shaved and swabbed with Betad · Al h · · · ine co olic solution (Napp Laboratories 
Limited, Watford), an established germicidal and bacteriacidal agent. 
Adrenalectomy was carried out through a median dorsal skin incision. 
A cut was made in the body wall, over the anterior pole of each 
kidney, and the adrenal glands carefully removed by means of angled 
forceps. The body wall incisions were sutured.with sterile silk 
thread (AR306, Armour Pharmaceuticals Limited, England), the sponges 
inserted, and the wound closed with sterile l? mm. metal suture clips. 
The wound was sprayed with Nobecutane (Astra Chemicals Limited, 
Watford), a plastic wound dressing, to prevent infection. The 
surgical instruments used throughout the operation had previously 
been sterilized by autoclaving for 20 minutes at a pressure of lSlbs./ 
sq.in. and the operation carried out under a microbiological screen. 
The animals were allowed to recover and maintained on normal laboratory 
diet, (Yilsbury's, England) and given 0.9% (w/v) saline ad Libitum 
Four days after implantation of the sponges the animals were 
killed by a blow to the head, the sponges removed and the exudate 
collected in sterile centrifuge tubes by manual squeezing. This 
procedure was carried om: under sterile conditions, as previously 
described. The exudate was centrifuged at 2000 r.p.m. for 30 minutes 
in an MSE bench centrifuge to remove cells, fibrin clots and other 
debris. The fluid was dialysed against distilled water at 4°C with 
at least three changes of the external fluid . The exudate was then 
freeze dried and stored in a sealed, sterile bottle at -30°C until 
required. All glassware in contact with the exudate and dialysis 
· 1 t 1."lized Also all transfer operations were tubing were previous y s er • 
Under a ml.·crobiological screen. carried out 
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2.1.5 Production of Liver Extr t fro · ________________________ ac_~----m Dimeth.iln~!rosamine 
treated_rat~. 
Liver extracts were p.,.,,,pa~ed f~om 1 · 
·~ L L 1.vers of rats that 
had received intra-peritoneal inJ'ections of o 5 3 . cm. dimethylnitro-
s amine in 0.9% saline (25mg/kg body we1.··g.ht) three days earlier . 
The livers from these animals wer~ homogenized for 30 seconds in 
i ce cold 0.9% saline (40 cm. 
3 
0.9% saline for every 20g. of 
freshly excised liver). The cell debris were removed by centrifugation 
at 100,000g for 30 minutes in an MSE superspeed ultra centrifuge. 
The clear supernatents were then pooled, dialysed overnight at 
4°C against 0.9% saline, freeze dried and stored at -3o0 c until 
r equired. 
2 .2.l The Fractionation of Pooled Human Rheumatic ·synovial Fluid 
The process of gel filtration was used to separate 
t he anti-inflammatory substances present in human rheu~atic 
s ynovial fluid. 
The pooled human rheumatic synovial fluid was partially 
fractionated by eluting 5 cm. 3 of the pooled synovial fluid through 
a Pharmacfa (Uppsala) column (SR25/100) 2.5 cm. in diameter and 100 
cm. long packed with Sephadex G-J.50 (Pharmacia), using a 0.lM phosphate 
buffer pH7.4 as eluant. The technique of upward elution was 
3 ·-1 
utilized with flow rate of 20 cm. h 
The column eluate was monitored at 280 mm. using a 
Uvicor~ II flow through cell (L.K.B. Instruments, England) con11ected 
3 . b 
to a strip chart recorder and collected in 10 cm. fractions y an 
Ultrorac 7000 automatic fraction collector (L.K.B.). The fractions 
were then pooled with reference to the elution pattern, dialysed 
for 24 hours at 4°C, freeze dried and stored against distilled water 
at -3o0 c until requi red for use. 
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2.2.2 Fractionation of s . 
------------------E~~~~~:~~~~~~-!nflammatory_~~~~!~ 
The method u d · 
se 1.n this case was the same as that used 
to fractionate human rheumatoid synovial flu1.·d 
except for minor 
changes. In this case the eluant 
wa~ 0 .5M sodium chloride containing 
a 0.003M sodium azide (to prevent 
bacterial growth) and 500 mg. of 
material was applied to th 1 3 e co umn dissolved in 5 cm of eluant. 
This method is the same as previously described by Billingham, 
Robson and Robinson (1969). 
2.2 .3 ~~~~!f~~~!f~~-~f_Liver_extracts_from_Dimethrlnitrosamine 
treated_rat~. 
A freeze dried extract of livers from dimethylnitrosamine 
treated rats (see Section 2.1.5) was fractionated by gel 
filtration. 
The sample (300 mg. in 2 cm. 3 <:!lt1tion buffer) was applied 
to the top of a column (K26/40 Pharmacia), 2 . 6 cm. in diameter, 
40 cm. long packed with Sephadex G-15J. The elution buffer was 
O.lM phosphate buffered, 0.9% saline (pH7.4) . The eluate was 
monitored at 280 mm. and collected in 10 cm.
3 
fractions, The 
proteolytic activity of each fraction was determined by incubating 
3 1 cm. of each fraction with azure blue hide powder (see section 
2. 5.4). 
3 The 10 cm. fractions were pooled on the basis of protease 
activity and possible irritancy since proteases are irritants when 
injected ~nto animals. The new fractions were then dialysed for 
24 hours, at 4°c, against water, freeze dried and stored at -30°C 
until required. 
2.3 The Induction and Partial Purification of Rabbit Antilodies to 
Rat Proteins 
An attempt was made to raise rabbit antisera against the 
exudate obtained from adrenalectomised donor rats and the proteins 
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contained within the exudate that inte~act . 
... with lysosomal 
membran~s. These proteins are of i'nte~est . ... since stabilisation of 
membranes may explain their t· · f 
an i-in lammatory activity. The 
antisera was produced using th h 
e met od described by Lewis , Capstick 
and Cosh (1975). 
Lysosomes were isolated from rabbit liver by the method 
of Lewis, Symons and Ancill (1969). F ' f i teen grams of fresh rabblt 
l iver was chopped into fine pieces and homogenized with chilled 
0 .25M sucrose in 0.05M tris-acetate buffer, pH7.4 so as to give a 
10% (w/v) homogenate. This was centrifuged at 700g for 10 minutes 
i n an M.S.E. bench centrifuge. The supernatent was retained and 
c entrifuged .at 15,000g for 20 minutes in an M.S.E. Superspeed 50 
ultracentrifuge. The resultant pellet was resuspended in fresh 
buffered sucrose, and centrifuged again, as above. The pellets were 
· 3 
then resuspended in 30 cm of buffered sucrose solution. 
Three flasks were then incubated for 90 minutes at 37°c 
each one containing 3 ·3 5 cm of the lysosome suspension, 2 cm of a 
-3 
100 mg.cm solution of the exudate from adrenalectomised donors 
and 1 cm
3 
of ·0.25M sucrose in 0.05M Tris-acetate buffer, pH7.4. 
After incubation the mixtures were centrifuged at 20 , 000g for 30 
minutes in an M.S.E. Superspeed 50 ultracentrifuge . The pellets were 
then washed with large excess of saline (0.9% w/v) frozen and thawed 
three times and centrifuged again at 40,000g for 30 minutes . The 
pellets were stored at -30°c until needed for injection. 
One third of the material isolated above was resuspended 
3 3 steri'le saline (0 . 9% w/v) and added to 1 . 5 cm of an in 1.5 cm of 
( Of fi·nely ground human heat-killed tubercle bacilli adjuvant 0.5 mg. 
3 ff· ) A ·stable water in oil emulstion wns per cm of liquid para in• 
formed by repentedly drawing the mixture through a narrow gauge 
syringe needle. New Zealand White rabbits, 1-2 Kg (J{ylyne Rabbits, 
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Cheshire) were injected intramuscularly 
at three different sites 
with 0.5 cm
3 
of the emulsion. 
The treatment was repeated after two 
weeks and after £our weeks to 
ensure a high circulating level of 
antibody. 
A similar procedure was adopted for t he production of an 
antisera to the exudate. I th · n 1.s case, however, 10 mg . of t he 
protein was re suspended in 1. s cm 3 of ste.,..,1.' le · ( 
L s aline 0.9% w/v) 
and treated as described for the pellets. 
After four weeks 20-30 cm3 of blood was taken from the 
r abbits by cardiac puncture; this was allowed to clot at 4°c and 
centrifuged for 10 minutes at 2000 r.p.m. in an M. S.E. bench 
centrifuge. Following this the immunoglobulin fraction of the rabbit 
ser um was partially purified by ion-exchange chromatography on DEAE 
cellulose (Sigma Chemical Company, U. S .A . ). A chromatography column 
(30cm. x 3 cm. diameter) was packed with 15g of DEAE cell ulose taken 
up in and equilibriated at pH7.5 with 0.0lM phosphate buffer , pH7 . S. 
A 10 cm
3 
sample of serum was dialysed overnight at 4°c against 0.0lM 
phosphate buffer, pH7.5 and applied to the column, t he same buffer 
being used to elute the column. The eluate from the col umn was 
3 
monitored at 280mm using an LKB Uvicord II and collected in 5 cm 
fractions by an LKB Ultrorac 7000 fraction collector . The fractions 
of the first protein peak contained mainly immunoglobulins and these 
were pooled, and dialysed against aquacide (flake polyethylene glycol, 
3 
Calbiochem, U.S.A.) to reduce the volu;ne t o about 3 cm . The fraction 
was then dialysed for 24 hours against a solut i on of 0 . lM sodium 
chl oride and 15mM sodium azide (to inhibit bacterial growth) and 
s tored at 4°c until required for use . 
The column was r estored by eluting it with 200 cm
3 
of 
a solution composed of 1.SM sodium chl oride and 0 . 3M phosphate buffer 
pH7.0, to release the r emaining bound protein . 
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The colwmn was then 
re-equili briated wi th 0.0lM phosphate buffer, pH7 . S, for further 
use . 
2.4 .l Inimunoelectrophoresis ·of ·Proteins 
1% (w/v) agarose (Sigma Chemical Company , U. S.A. ) in 
6mM sodium barbitone- sodium ace'tate buffer, pHB.6, was liquified 
in a water bath a t 100°c . Wh f en ully liquified, and free from 
l umps, the agarose solution was allowed to cool to ss0 c and poured 
onto an immunoelectrophoresis tray (Shandon, Cheshire) fitted with 
microscope slides. A perspex scrapP-r (Shandon) was t hen passed over 
the t ray to remove the surplus liquid agarose. The agarose gel 
was allowed to set leaving a 1 mm. thick layer of gel cover i ng the 
s l ides. A slot 30 mm. x 1 mm. was cut out of the agar ose gel 
down the centre of ~ach slide. Two holes, 1 mm. diameter , wer e cut 
opposite each other either side of the slot 3 mm. from i ts edge and 
about 10 mm . from one end. l µl of serum or protein solution was 
applied to each hole with a microsyringe (Hamilton Mi cromeasure , 
Switzerland. ) . The sl ide tray was then placed in a Shandon 
e lectrophoresi s t ank which contained 6 mM sodium bar b~t one-sodium 
acetate electrode buffer, pHB.6. A voltage of 100 volt& was applied 
across the agarose gel such that the protein migr at ed parallel with 
the edge of the slot towards the anode . The mi gration of the protein 
was vi3ualised by a drop of bromophenol blue, the electrophoresis was 
stopped when the bromophenol blue reached the end of the slot , the 
dye having travell ed 20 mm. The slot was fil l ed with t he appropri ate 
antiserum, which was allowed t o diffuse into t he gel for 12 hours . 
In this manner the antibody and ant i gen ar e brought together within 
the agarose gel to form an antigen-antibody complex which becomes 
vis ible as a white precipitin arc . This precipitin arc may then be 
examined by dark ground illumi nat i on (Phot opol lamp , Shandon} or 
may be visualised by staining with amidoblack . The staining was 
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accomplished by first irmnersing the 
agarose gel in O. 9% (w./v) 
saline for 12 hours to remove 
. . any non-precipitated proteins. The 
arcs were stained by immersing th 
e gels in a solution of 1% (w/v) 
amido-black in 7% (v/v) acetic acid for 
one hour. The background 
staining in the agarose g 1 th e was en removed by washing the gel in 
7% (v/v) acetic acid unt'l th 
J. e stained arcs were visible against 
a clear backgr·ound. 
Rabbit irnrnunoglobulins against whole rat serum, whole 
human serum, human alpha-2-macroglobuli'n and human alpha-1-anti-
t rypsin were obtained from Dako-immunoglobulins, Denmark. 
2. 4. 2 Quantitative_~stimation_of_SEecific_Protein~-~l 
Electroi!innunE As~~l 
The method of "rocket" immunoelectrophoresis developed 
by Laurell (1966) was used. In this technique the antigen under 
i nvestigation was induced, by an electric field, to migrate into 
an agarose gel layer, containing a mo~osper.ific antibody. 
The migration of this antigen, corresponding to the 
antibody, towarJs t he anode ceased when its concentration reached the 
equivalence point (i.e. when all the antigen has formed complexes 
with antibody in the gel). The height of the resultant "rocket" is 
proportional to the amount of antigen present. 
1% (w/v) agarose gel ir. 0.07M barbital buffer, pHS.6, 
containing 2mM calcium lactate was llquified in a water bath at l00°C. 
The agarose solution was allowed to cool to 40°C and the requisite 
amount of antiserum added. The antiserum concentration ~sed was 
the minimum one that had previously been found to form a distinct 
h t . The antisera to human alpha-1-precipitin line with t e an igen. 
antitrypsin and human alpha-2-macroglobulin (Dako immunoglobulins, 
Denmark) was mixed with agarose in the ratios of 1:50 and 1:75 
rP.spectively. A l5 cm
3 portion of agarose containing the antiserum 
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was then poured into a mould • 
consist~ng of two identical rectangular 
glass plates 20 cm . ~ 10 cm. spaced 1 mm. apart by a U-shaped 
former manufactured from l cm. wide polythene strips. The mould was 
clamped and held upright until the gel had set. The clamps were 
removed and 0ne gl ass plate slid away to leave a slab of gel 18 cm. x 
8 cm. x l mrr.. Holes 4 mm. in diameter were cut· th in e gel along 
the longest edge 2 cm. from the edge with the centres of the holes a 
minimum of 8 mm. apart. The gel 1 d · wasp ace in a Shandon electro-
phoresis tank with the line of holes perpendicular to the electric 
field and furthest from the anode. Eight mi~rolitres of the solution 
to be tested were pipetted into separate holes. For this procedure 
human synovial fluid and serum was diluted 1:15 and 1:10 to assay 
alpha-1-antitrypsin and alpha- 2-macroglobulin respectively, the 
dilutions being made with electrode buffer which consisted of 0.07M 
barbital buffer, pHS.6. A power pack was then used to apply a voltage 
of 70-80 volts across the gel. The electrophoresis was allowed to 
proceed for 18 hours by which time the height of the "rockets" 
remained constant. The voltage was then switched off and the height 
of the "rockets" measured from the centre of the holes to the peak 
· · t · 1 · l ' th 11ro~kets" tips using a dark field illuminator o easi y visua ise e - . 
Standar-d antigen solutions were examined during each electrophoretic 
run so that the results for different samples on different r11ns could 
be directly compared. 
2. 4.3. The_Testing_and_Use_of_Antisera_f 0 £_t~~-~~~!~!~2~_2!_~~!~-
Inflammato!1'.: Proteins_in_Inflammat2ry_Exudate 
----------- --
The antiserum produced in section 2.3 was first tested for 
purity by immunoelectrophoresis (see section 2.4 .1), inflammatory 
exudate from sponge implanted, adrenalecomised rats being us~d as the 
antigen. 
1 tested by immunoelectropho:resis using The antiserum was a so 
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normal rat plasma as antigen in order to eSt ablish i f proteins in the 
i nflammatory exudate which stabilised lysosomal membrane~ were 
normally present in plasma. 
3 Also, 0.5 cm of anti-whole 3 exudate and 0 . 5 cm of anti-
lysosomal membrane antisera were each m1· xed wJ'.th 3 1 cm of normal 
rat plasma, allowed to stand at 4°c • overn1ght, centrifuged to 
remove precipitated proteins and concent rated to about 0 _5 cm3 using 
Aquacide (Calbiochem). Th d'f' ese ma l. 1ed antisera were then tested 
by i mrnuno-electrophoresis using normal t ra plasma and sponge induced 
inf lammatory exudate as antigens. 
~. 5 Methods used in the assay· of Plasma a·nd ·T · s 1 _ 1ssue amp es 
The TIC activity of various samples was measured by the 
method described by Dietz, Rubinstein and Hodges (1974) , using the 
inhibitory action of the sample on the breakdown of alpha-N-benzoyl-
DL-arginine-p-nitroanilide (BAPNA) (Sigma Chemi cal Company , U.S.A. ) 
t o p-nitroaniline by trypsin (from bovine pancreas , twice crystallised) 
(Sigma Chemical Company, U.S.A.). 
A 2 cm3 portion of trypsin solution ( 20 
-3 . µg cm rn 0 . lM 
Tr is-HCl buffer, pHB.2, and 0.02M calcium chloride) was added to 10 µl 
. ( 3 ' of the sample. An aliquot of trypsin solution 2 cm) was also added 
t o 10 µ]_ of a 40 mg. cm. - 3 bovine serum albumin solution (Fraction 
V) (Sigma Chemical Company, U.S.A.) as a control. The solutions were 
t hen allowed to stand at room temperature for 10-15 minutes to 
activate the trypsin inhibitory proteins. 0.5 cm
3 
of this mixture 
3 ub ro 45 - 3 · were then added to 2. 5 cm of the BAP.NA s stra:t.e ,. . mg. cm rn 
O.lM Tris-HCl buffer, pHB.2 and 0.03-1 cal ci um chloride) and incubated 
0 
for 10 min. in a shaking water bath at 37 C. The reaction was stopped 
by the addition of 0 . 5 cm3 of 30% (.v/v ) aceti c acid. The samples 
were read against a blank at 400 mm. on a Pye-Uni cam Sp500 
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spectrophotometer. The bla,nks were prepared by arlding the sample-
trypsin solution to the BAPNA substrate after the incubation and 
addition of the 30% (v/v) acetic ac1.·d. A standard curve of the 
nbsorbance at 400 mm. of p-nitroaniline was also prepared. 
2. 5.2 TryEsin-Protein_E~terase_(TPE)_Activi!y 
The method used to determine the T.P.E. activity of various 
samples was developed by Ganrot, P. 0. ( 1966) , which enables the 
concentration of certain large molecular weight proteinase inhibito~s 
to be determined. These inhibitors can bind and inhibit trypsin 
so that it cannot breakdown large molecular weight substrates, such 
as proteins, but it can still degrade small molecular weight 
substrates, such as BAPNA. The activity of the bound trypsin is 
unaffected by soybean trypsin inhibitor . A 0.5 cm
3 
portb11 of 
t rypsin solution (100 µg trypsin per cm
3 
of 0.lM Tris-~Cl buffer, 
pH8.2 , and 0.02M calcium chloride) was added to 25µ1 of sample 
fluid , 0.5 cm3 of Tris-HCl buffer alone was added to 25 µl of a 
-3 40 mg.cm bovine serum albumin solution as a blank. After 10 
s econds 1.5 cm3 BAPNA solution containing soybean trypsin 
i nhibitor (Type II-S,Sigma Chemical Company, U.S .A.)(0.9 mg. BAPNA 
3 
and 66.8 µg. soybean trypsin inhibitor per cm 0.lM Tris-HCl buffer, 
pH8. 2, and 0.02M calcium chloride) was also added. The mixture was 
i ncubated for 10 minutes at 37°c in a shaking water b~Lh . The 
the addl..tion of 0.5 cm
3 of 30% lvh) acetic 
reaction was stopped by 
acid. l rea
d against the blank at 400 nm in a Pye-
The samp es were 
Unicam SP 500 spectrophotometer. 
2.5. 3 Estimation of Protein_Con~~~!£~!!~~ -------- --·---
Protein concentrations were estimated by the biuret 
procedure of Gornall, Bardawill and David (1949) . 
The biuret reagent 
• of 6mM copper sulphate, 2.lmM sodium potassium 
consisted of a solution 3 
5 cm of 
Sodium hydroxide and 6mM potassium iodide. tartrate, 0.8M 
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this reagent was added to 0.1 cm3 3 
sample, O.l cm standard protein 
solution (80 mg. p t · -3) ro em cm (Sigma Chemical Company, U.S.A.) and 
3 
0.1 cm of distilled water to act as blank. 
After standing for 
30 minutes at room t emperature the absorbance of the solutions were 
read against the blank at 540 nm on a p u · • ye- nicam SP 500 spectro-
photometer and compared with the standard protein solution. 
2.5 .4 Proteinase_Ac!i~f!l 
Proteinase Activity was determined by a method similar 
to t hat used by Rinderknecht, Geokas, Silverman, Lillard and 
Haverback (1968). AO 5 cm3 t' f 1 d 3 , por ion o samp e an 2 cm of O. lM 
Tris-HCl buffer, pH7.4, were incubated with 20 mg. of Azure 
blue impregnated hide powder (Calbiochem, U.S.A.) for twenty four 
0 
hours at 37 Cina shaking water bath. The solution was then 
cooled in ice and centrifuged for ten minutes, at 3500 g. to 
r emove any residual hide powder. The supernatent, containing the 
released blue dye, was recovered and the absorbance at 595 nm 
determined using a Pye-Unicam SP 500 spectrophotometer . A 
suitable blank for each sample was prepared by incubatiug the sample 
alone and adding it to the hide powder and buffer suspension 
immediately prior· to cent1,ifugation. A standard curve of the 
absorbance at 595 mm. of completely dissolved Azure blue impregnated 
hide powder was also prepared. 
2. 5.5 Quantitative_E~!f~!i~n_of_Putrescine_and_Cadaverine 
The levels of putrescine and cadaverine were determined 
using a modification of the method flrst describ~d by Seiler and 
Askar (1971). 
This method involves the r eaction of the diamine 
with 1-dimethylaminonapthalene-S-sulphonyl chloride (DANS-Cl, 
Sigma Chemical Co.) followed by two-dimensional thin-layer 
of the dansyJated derivatives, and 
chromatographic separation 
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fluorimetry of the DANS-putrescine and DANS-cadaverine extracted 
from the carrier. 
Freeze dried samples (200 mg.) 3 were shaken with 2 cm. 
of 0.2N perchloric acid for 15 minutes. Th e sample was then 
centrifuged for 10 minute- t 3000 3 .::; a g and 1 cm of t~1e supernatent 
used for assay. Exceptions to this procedure were endotoxin , where 
50 mg . was extraciEd, and dialysates where 1 cm3 was acidified with 
0. 2M perchloric acid and subsequently used for assay. 
3 -3 2.5 cm of a DANS-Cl clolution (4 mg.cm in acetone) was 
added to the sample and the reaction mixtures saturated with sodium 
carbonate. After completion of the <lansylation (by reaction over-
ni ght, in the dark, at room temperature), 10 mg. of D-proline ( Sigma 
3 Chemical Co.) dissolved in 0.2 cm of water were added i~ order to 
r eact with the excess DANS-Cl. After two hours, the dansylat~d 
amines were extracted from the reaction mixture with 2 x 10 cm
3 
of 
t oluene. The toluene was removed by evaporation under reduced 
3 
pressure and the resulting residues dissolved in 0 . 5 cm. of toluene/ 
ethyl acetate (7:3). 
Each sample was quantitatively ( 2G µ 1 or 40 µ 1 ) applied 
onto a separate 20 . x 20 cm. thin layer plate cons is ting of 250 µm 
layers of Silica Gel G ( BDH Chemicals). Standards were also applied 
to the plate as overleaf. 
Were developed in two dimensions, the solvent The plates 
system for the first dimension was trichlorethyleue-1.iethanol (19: 1) 
1 ( 19 • l '· and the sol vent for the followed by benzene-methano · 1 
· th lamine (10:1) which was 
second dimension was chloroforro-trie Y 
prepared immediately before use . 
t h thin layer plates we~e dried and After development, e 
Ultra
-violet lamp, where, the spots corresponding 
examint:d under an 
to putrescin~ and 














4 , irs irection; S2 = Standards, second S = Samp.le·, S1 = Standa~ds f. t d' · 
direction. 
s tandards. These plate areas were scraped out and the dansylated 
amines extracted from the carrier by shaking with 5 cm
3 
of ben~ene-
acetic acid (99:l). 
After standing for 5 minutes the carrier settled nut and 
the fJuorescent intensity of the extracts were measured at 500 nm; 
fluroescence was excited at a wavelength of 365 nm. 
The amounts of putrescine and cadaverinc were determined 
from previously prepared calibration curves. The calibration 
curves were obtained by taking solutions containing k~own areounts ~f 
pu.trescine 
samples. 
and cadaverine and treating these in the same way as the 
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2. 5. 6 ~~!i12!~!i~~-~~-~l2~~i~~--~~~-~~~~~~i~~ 
The levels of spermine and spermidine were determined 
using the method describ~d bv., Sei·ler and Wiechmann (1967). 
This method uses the · · principle of dansylation as employed 
in the assay of putrescine and cadaveri'ne d escribed earlier. 
Freeze dried samples (100 mg.) were shaken with 2 cm3 of 
0,2N perchloric acid for 15 minutes. The sample was thea 
centrifuged for 10 minutes at 3000g and 1 em3 of the supi:!rnatent 
used for assay. Exceptions to this procedure were endotoxin, where 
50 mg. was extracted and dialysates where 1 cm3 was acidified with 
0 •. 2N perch.!.oric acid and subsequently used for assay. 
0.4 cm
3 
of a DANS-Cl solution (30 mg.cm-3 in acetone) 
was adde~ to the sample and the reaction mixtures satur~terl with 
sodium carbonate. After completion of the dansylation (by reaction 
overnight, in the dark, at room temperature) 0.1 cm
3 
of a proline 
-3 solution (100 mg.cm. ) was added to remove the excess DANS-Cl . 




Each sample was quantitatively (20 µl) applied onto a 
thin layer plate consisting of a 250 µm layer of Silica Gel G. 
samples were appled 3 cm. from the bottom of the plate and 2 cm. 
apart, each 20 x 20 cm. plate consisted of four samples and five 
standards. 
developed usingethyl .acetate-cyclohexane The plates were 
(1: 1) with 1% triethylamine as solvent. 
Usi·ng this solvent system, were needed to get Two runs, 
a good separation. 
t t he thin layer plates were After developrnen, 
Under an ultra-violet lamp, where, spots dried and examined 
'd' were marked by comparison 
corresponding to spermine and spermi ine 
with the standards. 
were scraped out and the These plate areas 
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dansylated amines extracted from h t e carrier by shaking with 5 cm3 
of benzene-acetic acid (99 :1). 
After standing for f' • ive minutes the carrier settled out 
and the fluorescent intensity of the ext t rac s was measured at 
500 nm; fluorescence was excited at a wave length of 365 nm. 
The amounts of Spermine and spermidine were determined 
from previously prepared calibration curves. The calibration curves 
were obtained by taking solutions containing known amounts of 
sperrnine and sperrnidine and treating these in the same way as the 
samples. 
2.6 Determination of Degree of Stabilization of Guinea-Pig Macrophages 
The effect of inflammatory exudates (human rheumatic synovial 
fluid , sponge induced exudate), their fractions, and various other 
agents (endotoxin, oligoamines) on guinea-pig macrophages was 
investigated using the method of Lewis, Best and Bird (1977). The 
macrophages were isolated by injecting guinea pigs intraperitoneally 
with 100 cm3 of saline (0.9 w/v). 12 hours later this dose was 
repeated and the peritoneal cavity drained of fluid. The macrophages 
were harvested by centrifugation for 10 minutes at 1000g. in an 
MSE bench centrifuge. The macrophages were then washed in cold saline 
(4°c) and resuspended in 0.lM phosphate buffered saline, pH7.4 at 
• · f 7 - 3 as determined by the Biuret a protein concentration o mg.cm. 
method . The following flasks were set up for each teSt :-
a) Test 
2 cm3 macrophage suspension 
3 . 
1 cm test solution 
b) Control 
2 cm3 macrophage suspension 
1 cm3 phosphate buffered saline, pH 7.4 
' ·c) 'Blank 
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3 2 cm phosphate buffered saline, pH7,4 
3 
l cm test solution, 
All test solutions were prepared using O. lM phosphate 
buffered saline, pH7.4 and each test was duplicated. The flasks 
were then incubated for 90 minutes at 37°c i'n a shaking water bath, 
centrifuged at 2000g. for 10 minutes and th . e supernatents assayed 
for acid phosphatase activity (Symons, Lewis, and Ancill, 1969). 
Portions of the supernatents (0.1 cm3) were incubated 
with 0.5 cm
3 
of p-nitrophenyl phosphate (0.015M) and o.s cm3 of 
0. 09M citrate buffer, pH4. 8 for 30 minutes at 37°c in a shaking 
water bath . The reaction was s::opped by addition of 5 cm3 of O. lM 
sodium hydroxide solution and the results read at 410 nm in Pye 
Unicam SP 500 spectrophotometer, all tests being duplicated . 
2 .7 The Evaluation of Trasylol as a ·Potential Anti-InflammQtory 
2. 7.l The_Effect_of_Tras~lol_in_the_Cotton_Wool_Pellet_Granuloma_Test 
Rats which had previously been implanted with four cotton 
wool pellets (see section 2.1.2) were given i ntra-peritoneal 
i njections of 5,000 KIU and 10,000 KIU per Kg . body weight per day 
f or the duration of the experiment. Control rats were given 
i njections of 1.0 cm3 of 0.9% (w/v) saline alone per day. The 
e xperiment was repeated using doses of 20,000 KIU and 40,000 KIU per 
K Usi·ng a ten times more concentrated solution of g . per day, also 
50 ,000 KIU and 100,000 KIU per Kg. per day were used. Trasylol doses of 
(Trasylol donated by Bayer ij.K.Limited). 
2.7 .2 Trasylol_in_!~~_Adjuvant_Ar!~~!!!~-~~! 
· · ~ats were given daily intra-peritoneal 
Adjuvant arthritic• 
injections of SO,~OO KIU and 100,000 KIU per Kg. bodyweight from the 
t ·1 the end of the experiment. day of the injection of adjuvant uni 
· were given daily injections of 1.0 cm 
Adjuvant arthritic control rats 
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3 
of 0.9% (w}v) saline alone. 
2.7.3 The Inhibition of Neutral p t · · ---------------------------E~ einases in Hl.llDan 'Rheumatoid ----------------------------
Synovial_Fluid by_!E~~y~~~ 
A modification of the method described in section 2.5.4 
was used to determine the inhi>i iDr:y effect of Trasylol on proteinase 
activity in human rheumatoid synovialfluids. In this instance 1 ml. 
of Trasylol (10,000 K IU per ml. )was substituted for 1 cm 3 of the 
buffer , the assay being identical in all other respects. 
2 ,8. The Levels of Prciteinases ·and ·Anti-proteinases in Human 
Rheumatoid Syncivial Fluid 
Synovial fluids were aspirated from the knee joints of 
patients with a rheumatic disease. The fluids were centrifuged at 
7,500 r.p.m. for 25 minutes at 4°C to remove the cells and debris. 
The cell-free fluids were then stored at - 30°C , in airtight 
containers, until required for use. The following tests were then 
carr ied out on the fluid samples:-
a) Total Protein Levels (see Section 
2.5 . 3) 
b) Proteinase Levels (.see 
Section 2.5.4} 
c) TIC Levels 
(see Section 2. 5.1) 
d) T.P.E. Levels 
(see Section 2.5.2) 
e) Alpha-1-antitrypsin levels 
(see Section 2.4.2) 




·ected to a linear regression analysis 
The results were 
ff . · nt significance were also . t t-values for coe icie using a compu er, 
calculated. 
. 't ·of Human Rheumatoid Synovial Fluid 
2 ;g The Anti.:.Irtflammatciry Activi Y 
Oedema in the Rat ----------------- inJ·ection of carrageenan rats were given 
One hour prior to 
1.0 cm3 of a human rheumatoid synovial 
intra-peritoneal injections of 
SS 
fluid. The rats received an add·t· 3 i ional dose of 1 . 0 cm of the 
synovial fluid at·the time of· · • inJection of t he carrageenan. 
Control rats were given injections with 3 l.0 cm of 0.9% (w/v) 
saline alone instead of the synovial fluid. 
2 .9 . 2 The Evaluation of Huma Rh · --------------- n eumatoid Sy_novial Fl 'd . h --------------------- _________ ui __ using_!_~ 
Cotton_Wool_~~!!~t Granuloma Test -------------
Rots which had previously been implanted with four cotton 
wool pellets were given intra-peritoneal injections of 1 .0 cro3 of 
a human rheumatoid synovial fluid per day for the duration of the 
experiment. Control rats were injected with 1.0 cm3 of 0.9% (w/v) 
saline alone per day. 
2.9 .3 Anti_Inflammatory_activity_of_Pooled_Hurnan_Rheumatic_Synovial 
Fluid and Fractions -------------------
The resulting fractions prepared from pooled human 
rheumatic synovial fluid in section 2.2.1 were assayed for anti-
inflammatory activity using the carrageenan oedema test . Each group 
3 -3 . 
of rats received l cm of a 100 mg.cm solution of one fraction 
intraperitoneally, this being compared with rats receiving intra-
pe~itoneal injections of 1 cm3 saline (controls) and 1 cm
3 
of the 
pooled human rheumatic synovial fluid. 
2. 9.4 The Irritant Effects of Human Rheumati~_§Y.~~~!~!_r!~!~-~~~ ----------------------------------
Its Fractions 
The irritant effects of the synovial fluid used in section 
2. 9. 1 and of the pooled synovial fluid and fractions from it 
d b a method similar to the one first (section 2.9.3) were assesse Y 
described by Atkinson and Hicks (1971). 
In this case the 
evaluated by measuring the increase in paw irritant activity was 
3 . l 
volume following a subplantar injection of 0.05 cm of the synovia 
· (see above), into the left hind 
fluid, or a solution of its fractions 
foot. 
Control animals being injected with 0 .05 cm3 of 0 . 9% (w/v) 
saline alone. 
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2. 9. 5 Elucidation of the M h · . _________________ ec anism of Action of H ok · __________________________ uman_!)'~euroati~ 
Synovial_Flu~~ 
It was decided to investi'gate h h wet er the anti-
infl ammatory effect of this exudate was d ue to large molecular 
weight substances or to small molecules f or ragments of larger ones . 
To accomplish this a modification of the carrageenan 
oedema test was used. 
Ten days prior to injection of carrageenan rats were 
anaes thetized using a Boyles veterinary anaesthetic trolley as 
previ ously described. Using a sterile operating procedure (see 
secti on 2.1.4) a median dorsal skin incision was 1nade and a dialysis 
sac, (5 cm. long, 1 cm. diameter)(Gallenkamp and Company Limited, 
Birmingham) which was sealed at both ends, was inserted along the 
back. The wound was closed with 10 mm . metal suture clips. The 
dialysis sacs had previously been sterilized by autoclaving for 20 
minutes at a pressure of· l5lbs. per sq. in. and had been filled 
with the appropriate solution under a microbiological screen, the 
solutions having been sterilized by filtration using a 0.22µ m membrane 
filter (Millipore (U.K.) Limited, London). 






Sham operated controls. 
• containing 1 cm
3 
of 0.9% (w/v) Dialysis sacs 
saline alone. 
3 -3 
Sacs Containing 1 cm of a 150 mg.cm. Dialysis 
Of h:uman rheumatic synovial fluid. solution 
this treatment a carrageenan test was days after 
carried out as previously described. 
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2.9 .6 ~~!~EIE!~~!!on of the De . . . ------------~~~-~!-st<il21 lization of Guinea-Pig 
Macronhaues b Hu • -------------------~--2 ____ z_ man Rheumatic Svnovial Fl 'd d. 
-----------------~~--------~~--~~ its 
Fractions ---------· 
Using the -method previously d escribed (section 2.6) the 
effect of human rheumat· · ic synovial fluid solutions (200,100,10 and 
-3 . 
l mg. cm. } and the fractions produced by gel filtration (200,100, 
.:.3 
10 and l mg.cm. } on the stability of guinea-pig macrophages was 
investigated. 
2.10 'The Anti~irtflarimiatory Activity ·of .Liver Extracts from 
Dimethylnitrosamine Treated Rats 
2.10.l The_Effect_of_Fractions_of_Liver _Ext r acts_from_Dimethylnitro-
samine_Treated_Rats_on_the_Carrag~e~~~-2~~~~-~~~~! 
The samples prepared by the gel filtration of dimethyl 
nitrosamine (DMN0) liver extracts (section 2 . 2. 3) were assayed for 
anti-inf lammatory activity using the carrageenan oedema test. Each 
3 -3 
group of rats received l cm of a 100 mg. cm solution of one fraction 
intraperitoneally, this being compared wi th rats receiving intra-
peritoneal injections of 1 cm
3 
saline alone. 
The irritancy of these fractions was also measured (see 
section 2.9.4) and compared to saline. 
2.10.2 The_Release_of_~~~!y~able_Molecules_by_DMNO_Liver_Extract 
and_Fractions 
It was decided to determine i f DMN0 liver extract or 
the anti-inflammatory fractions self degraded in any way to 
release small dialysable molecules . 
Thi s was accomplished by setting 
o cm3 of 0.0lM phosphate 
up four conical flasks each containing 5 
Each flask also contained an identical 
buffered saline, pH7.4, 
l cm. diameter), which contained one of 
di alysis bag (5 cm. long, 
the f ollowing solutions:-
Flask 1 






l cm of a 100 mg. cm-3 solution of 
the test material 
as flask 2 plus 10 mg. of trypsin 
l cm
3 
of 10 3 mg.cm solution of trypsin 
The flasks · were incubated at 37oC in a shaking water 
bath and the bathing fl. uid sampled at 30 minute intervals for 
three hours and read at 280 mm. using a spectrophotometer. 
2.10.3 ~!~~~~ation of the M h • . --------------~~-~~ism of Action of DMNO L" -----------------------!ver Extract 
Fraction -----------
--------
In order to determine if the release of dialysable material 
was important in vivo an experiment .. similar to the one described in 
section 2.7.5 was carried out . 
. Dialysis sacs were implanted subcutaneously into rats . 
Three groups of rats received one of the following 
treatments:-
a. Sham operated controls 
b. -Dialysis sacs containing l cm
3 
of 0.9% saline 
c. Dialysis sacs containing 100 mg. of the fraction 
and lo t .. 1 
3 f . mg. rypsin in cm o saline. 
Ten days later a carrageenan test was performed. 
2. 10. 4 ~~_Role_of_Oligoamines_in_the_Mechanism_of_Action_of_D~~2 
~iver_Extracts 
Using the methods previously described (2.5.5 and 2.5.6) 
liver extracts from DMNO treated and normal rats were assayed for the 
presence of spermine, sperrnidine, cadaverine and putrescine. 
In addition, in an experiment similar to the one carried 
out above (2.10.2) the dialysate of a DMNO extract was examined for 
oligQlmines. This experiment used the same method as before, but in 
this case aseptic techniques were employed throughout. The bat hing 
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fluid consisted of 100 cm3 
of buffer and the sealed flasks were 
incubated for seven days, 1 cm 3 of the 
dialysate was then used for 
analysis. 
2.11 ·The ·Artti~irtflarimiatory ·propertie~ ·of ·Exudate from Sponge 
Implanted Rats 
2 . 11. l Determination of the Degree f Stab· · · ____________________________ o ______ ilization_of _Guinea-eig 
~~~~~E~~g~~-~l-~E~~g~_~xudate_and_Its Fractions -------------
Using the method previously described (section 2.6) the 
effect of sponge exudate solutions (100,50,10 and 1 mg . cm-3) and the 
fractions produced by gel filtration (100,50, 10 and 1 mg.cm-3) on 
the stability of guinea-pig macrophages was investigated. 
2,11.2 The_Proteolytic_Activity_of_SEonge_Exudate 
Proteinase activity was determined using a modification 
of t he method previously described (2.5.4). In this case the 
3 _ample was 1 cm of a 100 mg.crn- 3 solution of sponge exudate and the 
quantities of buffer and substrate were doubled. 
It was also decided to determine if the sponge exudate 
self .degra&d in any way and what was released during this process . 
This was investigated using the method described in section 2.10.2. 
2. 11.3 ~~~~~~~!!~~-~!_!~~-~~~~~~!~~-~~ Action_of_Seonge_Exudate 
Using the method previously described (2.9.5) dialysis 
sacs were implanted subcutaneously into rats to determine the 
importance of the release of dialysable material. 
Five groups of rats received one of the following treatments :-
a. Sham operated controls 
containing 1 
3 of 0 . 9%(w/v) saline 
b. Dialysis sacs 
cm 
3 -3 
Dialysis sacs containing l 
cm of a 100 -mg. cm 
c. 




Dialysis sacs containing 1 cm3 of a 100 mg.cm-3 
solution of sponge exudates plus 5 mg . of trypsin 
Dialysis sacs containing 1 cm3 of a 5 mg . cm-3 
solution of trypsin. 
Ten days later a carrageenan oedema test was carried out. 
2 .11. 4 The Ant i-inflamrnatoT'V Acti vi t f s E · -------------------~~ ________ y_o ___ E~~g~ __ xudate_Dialysate 
Dialysate molecules released by sponge exudate were 
tested for their anti-inflammatory activity. 
The dialysate was collected by dissolving l . Sg of 
aseptically derived exudate in 50 cm3 of water and placing this 
in a sterile dialysis sac. The dialysis sac was then immersed in 
100 cm
3 
of water in a flask using aseptic techniques. The sterile 
water was changed every two days until the end of the ten day 
incubation at 37°c. 
After removal the dialysates were freeze-dried, pooled 
and stored at -1s0 c until required. 
3 
The freeze-dried powder was dissolved in 15 cm of water 




Three groups of rats were treated as follows: -
1 cm3 saline intraperitoneally one hour prior to 
the carrageenan. 
3 d' 1 t solution intraperitoneally 1 cm of the ia ysa e 
one hour prior to the carrageenan. 
Cm3 ·of the dialysate solution, subcutaneously 0.1 
starting ten days prior to the carrageenan. 
also tested for irritancy and the 
The dialysate was 
was tested both for anti-inflammatory 
residue left after dialysis 
d being 100 mg. per rat. 










2 .11.5 The Role of Oli(Yoa · · 
----- ----------Q--~~~~~-~~-!~~~~~hanism of Action of 
-------------------Seong;e_Exudate 
The levels of spermine, spermidi ne , cadaverine and 
putrescine were determined in sponge exudate , normal serum, serum 
from sponge implanted rats and dialysat es of sponge exudate (2 .10.4). 
2. 1 2 The Role of 0ligoamines iri Inflaniniation 
2.12. l The_Anti- inflammator;z_Activity_of_Ol igoamines_in_the 
~~~~~g~~~~~-2~~~~~-!~~t 
Using do~es of 50 µ g, 500 µ g and 5,000 µ g per Kg body 
weight gi ven intraperitoneally in 1 cm3 of 0 . 9%(w/v) saline the 
four oligoamines spermidine, spermine, cadaverine and putrescine 
were tested using the carrageen oedema model , the compounds 
being given one hour before the carrageenan . 
The same solutiorswere also used t o test the irritancy 
of each oligoamine . 
2 . 1 2.2 The_Inhibitory_Effect_of __ Oligoaroines_on_Pinnal 
AnaEhylaxis_in_the_Mouse 
Using a fixed dose of 50 µg per Kg bodyweight given 
i·n 0 .1 cro
3 of saline t he four oligoamines were intraperitoneally 
tested for their effect upon the development of a local anaphylactic 
reaction in the mouse pinna. 
The Anti-inflammatorv_Action_of _P~t E~~~!~~-~~-!~~ 2.12. 3 ----------------- ~ 
Adiuvant_ArthE!!!~-~~t 
. subcutaneous injections of 50 µg and The effect of daily 
o 5 cm3} upon the development 500 µg per Kg body weight (dose -volume . 
. . h at was i nvestigated. of adj uvant arthritis inter 




. spermine, spermidine, Solutions of the oligoamines 
concent rations of 10 µg, 100 µg, 
cadaverine and putrescine at 
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-3 
1 mg. and 10 mg.cm were made up . 
. · using phosphate buffered saline 
and their effect on the stability of gu· . 
. inea-pig macrophages 
measured. 
2. 12. 5 !~~-~~!~=~~~~~~!~~Y-~~!~~~!Y_~~-!~~~~~!~!~~_an~ 
Theonhvlline in the C ----~-~--------------~~~g~~~~~_0edema Test -----------
A single dose of thioacetamide (150 1!lg Kg-1) given by 
intraperitoneal injection twenty four ho · . · urs prior to the carrageenan 
was evaluated for its anti-inflammatory act;on Th h 1 · ... . eop y line 
-1 
given orally (15 mg._Kg ) for the previous two days was also 
evaluated. 
2.13 The Role ·of Endotoxin ·in ·Jnflammation 
2. 13. 1 The_Anti-inflammatory_ProE_erties_of Endotoxin 
The anti-inflammatory effect of bacterial endotoxin 
(E . Coli: serotype 0111: B4, Sigma Chemical Co., U.S.A) on the 
development of carrageenan oedema in the rat was investigated . 
Doses of 5 µg, 20 µg and 100 µg per Kg. bodyweight were administered 
intraperitoneally one hour prior to the carrageenan. 
The irritancy of a 100 µg cm.-3 solution of the endotoxin 
was also measured. 
2.13. 2 Determination_of_the_Degree_of_Stabilization_of_Guinea-2ig 
MacroEhages by_E~~~!~~~~ 
The effect of bacterial endotoxin solutions (100, 50 , 10 
and l µg.cm.- 3) on the stability of guinea-pig macrophages was 
investigated as previously described (2.6). 
The bacterial. endotoxin used in the above experiments 
leve
ls of spermine, spermidine, cadaverine 
was also assayed for the 
and putrescine present. 
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3; . RESULTS 
3.1 The Evaluation of Trasylol as p 
a ot ential Anti-Inflammatory 
For methods see section 2. 
3.1.l The Effect of Trasvlol · th c - -----------------~-___ in ___ e_ otton Wool Pellet -------------
Granuloma Test 
Trasylol when given in daily doses of 5,000, 10,000, 
20 ,000,40,000, 50,000 and 100,000 KIUper Kg body weight, by 
i ntraperitoneal injection, to rats impl~nted with cotton wool 
pellets show ed no tendency to inhibit the formation of granulation 
t issue around these pellets. 
3. 1. 2 The Action of Tras:zlol in the Adjuvant Arthritic Rat ------------------ ---------------------------------
In this model doses of 50,000 and 100 ,000 KIU Kg-l of 
Trasylol were ineffective in inhibiting the inflammatory response 
caused by the adjuvant. The animals treated with Trasylol showed 
a significantly (p < 0.05) greater increase ·in foot volume of 
the injected foot when compared to the controls after day 12 of 
the e xperiment. 
3.1.3 The Inhibition of Neutral Proteinases in_~~~~-~b~~~~!!~ --------------------------------
Synovial_Fluid_by_Trasylol 
Table 3 .1 shows to what extent ~asylol inhibited the 
· • · 1 fluid samples from patients proteolytic action of human synovia 
both male and female, with various rheumatic conditions. 
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'Table ' 3.1. 
Disease 
State 
. . . . . . .. .. . ... 
Sex 





























% Inhibition of 
Protei nase Activity 
by Trasylol 
33 . 8 
61. 4 
8 . 1 
9 . 2 
70 .0 
22 .9 
38 . 8 
38 . 9 
27 . 8 
89 . 5 
2 . 2 
87 . 8 
77 . 8 
95 . 9 
93 . 2 
92 . 95 
43 . 8 
Table 3.1. The percentage inhibition of proteinases 
in human rheumatic synovial fluid samples by Trasylol. 
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3 ;2 · 'The ·1evels · of ·Proteinases · and ·Ant· · t • 
i-pro einases in Human 
Rheumatic ·synovial ·r1uid samples 
Table 3.2 shows the levels of alpha-1-antitrypsin, 
alpha-2-macroglobulin, trypsin inhibiting capacity (TIC), trypsin-
protein esterase activity (TPE), proteinase activity and total 
protein in samples of synovial fluid withdrawn from patients of 
bot h sexes , suffering from a variety of rheumatic conditions. A 
t otal of 21 samples were used in this study. 
The results from the study carried out above were entered 
into a computer which was programmed to analyse groups of data by 
linear regression and calculate the significance of these results . 
Table 3.3 shows the significance levels calculated by the computer. 
In addition to the data presented in this table the 
ratio of alpha-1-antitrypsin levels to alpha-2-macroglobulin levels 
The against proteinase activity was also subjected to analysis. 




lrun@ a2. 1n e2"'±€ 0 @1 & , ¥44?J iid i iiAA-IS .C Aiiil A ll i.I pr oce ± ndsc ±Ii ii U ilit dl Z UC W ild C .LC 
synovial fluid samples. -
alpha-1- alpha-2- TIC TPE Protease Total Se x/ 
a n t i trypsin macro globulin Levels 
-1 -3 
Levels Levels Protein 
3 
Disease 
umol min cm ;'c g/100 cm State 
20 6 0. 96 0 .095 0. 29 5.28 M,RA+ 
13 4 0.43 0.051 6.16 5 .68 F,RA+ 
18 4 0.52 0.063 0.58 4.44 F,RA+ 
14 5 0.56 0.082 o. 71 5.26 M,RA+ 
27 9 1.04 0.017 7.12 7.49 F,RA-
22 4.5 0.59 0.094 14.45 7.18 M,RA-
11.5 7 0.42 0.030 0.87 6.12 F, 
6.5 2 0.17 0.039 0.54 3.36 M, 
9 2 0.42 0.039 0.40 5.19 M,0A 
11.5 3 0.65 0.000 0 . 80 5.35 F,RA+ 
13 4 0.61 0.000 8 . 84 8.53 F,RA+ 
8 2 o. 32 0.043 0.70 5 . 52 F,CH 
8.5 3 0.27 0.045 0. 93 5.08 F, 
9 . 3 0.37 0.000 - 4.38 F,0A 
7 6 0.01 0.000 2.01 4.73 F,RA+ 
4 4 0.00 0.000 2.01 5.19 M,RA+ 
9 3 0.06 0.000 1.43 5.97 
12 6 0.00 0.000 2.15 6.78 F,RA-
9 3 0.35 0.029 2. 71 4.18 F ,RA:t-
7 2 0.32 0.000 5.46 5.33 F, 
10 1 3 0.47 0.080 2. 24 7.18 M, . . 
M, Male ; F , female ; RA+, Rheumatoi d a rthritis serapositive ; RA-, Rheumatoi d arthritis 
seranegative ; 0A, osteoarthriti s ; CH , chondrocal c i nosis . 
* mg . of substrate broken down in 24 hours. 
Table 3.3 The Significance levels between various parameters 
as determined by computer analysis. 
alpha-1- alpha-2- TIC TPE Proteinase anti- macro-
trypsin globulin 
. . 
alpha-1- 90.5% 96 . 9% anti trypsin 
90.5% 81.4% 73 . 7% 29 . 8% alpha-2-
macro globulin 
TI C 81.4% 78. 5% 
TPE 73.7% 24 .6% 
Pr oteinase 96.9% 78.5% 24.6% 
Total 97.9% 99. 6% 
Protein 




97 . 9% 




The · Ariti ..:.iriflanirilatory A . • • 
- ctivity ·of Human Rheumatic 
Fluid ynovial 
!~~-~££~~!-~£-~~~~~-~~~~!!~-§~~~~~-Fluid on the 
~~~~~g~~~~~-2~~~~~-~~ the Rat --------
Figure 3 .1 shows the effect f . 
o intraperitoneal injections 
of a human rheumatic synovial fluid on 
carrageenan induced oedema 
in rats. This treatment significantly 
reduced the carrageenan oedema 
when compared to control animals 
treated with saline alone. 
The rheumatic synovial fluid chosen f or this experiment 









-1 -3 0.96µmole min cm 
0.095 
0.29 mg broken down in 24 hours 
5.28g per 100 cm3 
This synovial fluid was also tested for its irritant 
properties by injecting 0.05 cm~ into the subplantar region of the 
l eft hind foot of rats. There was no significant difference between 
t hese animals and animals injected with saline only (see Figure 3 . 2). 
3.3. 2 The_Evaluation_of_Hum~~-~eumatic_Synovial_Fluid_using_the 
Cotton Wool Pellet Granulorna Test ---------------------------------
3 
Daily intraperitoneal injections of 1 .0 cm of human 
rheumatic synovial fluid had no effect on the formation of granulation 
tissue around cotton wool pellets as can be seen in table 3.4. 
in pellet weight Treatment Mean Increase 
+SEM (mg) . . -
Control . .10.12 ±· . .0.44 
Human Synovial .Fluid . 10.37 .+ 0~41 









Figure 3.1 Increase in foot vol ume of rats injected with 
3 carrageenan one hour after administration of 1 cm of human 
rheumatic synovial, which was repeated at the time of 
injection of the carrageenan .__. . Increase in foot volume 
of control rats injected with carrageenan o---o. 







0 3 6 
Time (h) 
Figure 3. 2 Increase in foot volume of rats injected with 0.05 cm3 
of human rheumatic synovial fluid into the left hind foot pad 
e-e compared with controls injected with saline alone o---o 
Each r esult represents the mean of six animals+ SEM 
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3.3.3 The_Fractionation_of_Pooled_~uman_Rheumatic_Synovial_Fluid 
The elution pattern obtained when 5 cm3 of pooled human 
rheumatic synovial fluid was fractionated by gel filtration on a 
Sephadex G-150 column (100 x 2.5 cm) is shown in f1gure 3.3. The 
elution profile consisted of an initial broad peak followed by a 
small secondary peak. The column fractions were pooled to give 
two new fractions, 'fl and F2 as indicated. These fractions, after 
freeze dryi_ng, were used in subsequent experiments. 
3.3.4 The_Anti-inflammatorY._Activity_of Pooled_Human_Rheumatic 
Synovial_Fluid_and_Its_Fractions_Fl_and_F2_ 
Figure 3.4 demonstrates: the effect of intraperitoneal 
injections of fractions Fland F2 on carrag~enan induced oedema. 
Fractions Fland F2 significantly reduced the formation of the 
oedema when compared to intraperitoneal injections of saline alone 
and pooled human rheumatic synovial fluid. The significances of 










100 180 260 340 420 500 560 
Elution 
Volume (cm3) 
figure 3.3 The protein el ution pattern of human rheumatic synovial 
fluid through a sephadex G-150 column in O.lM phosphate 
buffer, pH7 . 4 . The absorbance at 280 nm of the eluted proteins 






0 3 6 
Time (h) 
Figure 3.4. Increase in foot yolume of rats injected with 
carrageenan and treated with human rheumatic synovial fluid 
••--• , fraction Fl D---0 , fraction F2 *--* 
and saline alone Q-0. 









Rheumatic p<0.l N.S. 
Synovial Fluid 
Fraction p < p< 
Fl 0.0025 0 .01 
Fraction p < p < 
F2 0.0005 0.05 
N. S. = not significant 
Rheumatic 
Synovial Fluid 




p < p (. 
0.05 0.025 




3h 6h 3h 6h 
p< p< p< p 
0.0025 0.01 0.0005 0.05 
p< p<. p<. 
0.05 0.025 0.01 N.S. 
- - N.S. N.S. 
N.S. N.S. - -
3.3.5 The_Irritant_Activi!l_~!-~~~led_Human_Rhe~tic_Synovial 
Fluid and Fractions Fland F2 -----------------------------
The irritant effects of subplantar injections of human 
rheumatic synovial fluid,fraction Fland fraction F2 are shown in 
figure 3.5. 
All of the test substances are significantly more irritant 
than saline alone and are also significantly different from each 
other. 
3.3.6 Elucidation of the Mechanism of Action of Human Rheumatic 
Synovial_Fluid 
The effect on carrageenan induced oedema of implanted 
dialysis sacs containing 150 mg. of human rheumatic synovial fluid 
can be seen in figure 3.6. Dialysis sacs containing saline alone 
and the sacs containing human rheumatic synovial fluid did not 

















Figure 3 .5 Increase in foot volume of rats injected with human 
rheumatic synovial fluid-----., fraction Fl o---a, and fraction 
F2 ¥-~ compared with controls injected with saline alone 
. o-o. 








0 3 6 
Time (h) 
Figure 3.6 The effect on carrageenan induced oedema of implanted 
dialysis sacs containing human rheumatic synovial fluid ----., 
and saline alone o--:> . 
Sham operated controls are also shownO----O. 
Each result represent s the mean of seven animals t SEM . 
7.8 
3.3.7 · The_Effect_of_Human_Rh~~!~c_S~ovial Fluid and Fractions Fl - - -----------------------------
and_F2 u~on_Acid_PhosE~~!~~~-~~lease_from_MacroEhages 
Figures 3.7, 3.8, and 3.9 show the effect of human 
rheumatic synovial fluid and fractions Fland F2 on the percentage 
release of acid phosphatase from macrophages. 
Figure 3.7 shows that human rheumatic synovial fluid inhibited 
the release of acid phosphatase from macrophages at very low 
concentrations,but this result is not statistically significant. At 
higher concentrations the rheumatic synovial fluid has a lytic 
action which is statistically significant. 
As can be seen from figures 3.8 and 3,9 both synovial 
fluid fractions significantly inhibit the release of acid phosphatase 
at all concentrations in a dose dependant manner, fraction F2 being 
more effective at this than fraction Fl the statistical significance 
being: -
Concentration 
-3 (mg.cm ) Significance 
. . . . . . . . . . . .. . . 
200 p < 0.10 
100 p< 0.0005 
10 p( 0.025 
1 p<0.025 
. . . . . . . .. . 
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Figure 3.7 The effect of rheumatic synovial fluid on the release 
of acid phosphatase from macrophages . 
Each result represents the mean of four observations ~ SEM. 
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Figure _3 . 8 The effect of fraction Fl on the release of acid phospha-
tase from macrophages~ 
Each result represents the mean of four observations+ SEM. 
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Figure 3.S The effect of fraction F2 on the release of acid 
phosphatase from macrophages. 
Each result represents the mean of four observations+ SEM. 
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3.4 The Anti-inflammatory Activity of Liver Extracts from 
Dimethylnitrosamine 'Treated .Rats 
3 . 4. 1 The_Fractionation_of_a_Liver_Extract_from_Dimethilnitrosamine 
Treated Rats 
The elution profile obtained when 300 mg . of an extract 
of livers of dimethylnitrosamine (DMNO ) treated rats was fractionated 
by gel filtration on a Sephadex G-150 coltnnn (40 x 2,6 cm.) is shown 
in figure 3.10. · The elution pattern consisted of two broad peaks. 
The proteolytic activity of each fraction, measured by 
incubation with A~ure blue hide powder, is shown in figure 3,11. 
This pattern indicated the presence of three peaks of proteolytic 
activity, an initial small peak followed by a second broad peak and 
finally a large sharp band. The 10 cm
3 
fractions, with reference 
to their proteolytic activity were pooled to form three new larger 
f ractions 11, L2 and 13 prior to freeze drying. These fractions were 
t hen used in subsequent experiments. 
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Absorbance 



















Figure 3.10 The protein elution profile of a liver extract from 
~MNO treated ·rats using a Sephadex G-150 column. The 
absorbance at 280 nm of the eluted proteins was measured. 
The column fractions were pooled to form Ll, L2 and L3. 
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Protease Activity 
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L2 
8 12 16 20 
Column 
li'raction 
Figure 3.11 Distribution of proteolytic activity in the eluate 
from a Sephadex G-150 column to which a liver extract from 
DMNO treated rats had been applied. The column fractions 




Figure 3.12 shows the results from an experiment to assay 
the anti-inflammatory activity of fractions Ll, L2 and L3 . 
Fraction 11 is significantly anti-inflammatory at both 
three and six hours when compared to saline treated controls . 
Fractions 12 and 13, however, demonstrate no statistically significant 
anti-inflammatory properties. 
3.4. 3 The_Irritant_Effects_of_Fractions_11,_~2_and_13 
The solutions used in the test above were injected into 
the subplantar region of rats feet to determine the irritancy of 
these fractions, the results may be seen in figure 3.13. 
In this experiment fraction 11 was seven times as 
irritant as saline and the irritancy of 12 and 13 were about twice 
that of saline. 
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Paw Volume 







Figure 3 . 12 The effect of fractions 11 •-•, 12 □-□ and 13 •-• 
(all 500mg. Kg-1 } on the increase in foot volume of rats 
injected with carrageenan, Controls were treated with saline 
only o~o. 








0 3 6 
Time (h) 
Figure 3.13 Increase in foot volume of rats injected with, fraction 
Ll •-•, fraction 12 □-□ and fraction 13 Jf--1'- compared 
with controls injected with saline alone 0- 0 . 
Each result represents the mean of five animals ~ SEM. 
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3.4.4 The Release of Dialvsable M 1 ul b · 
-------------------~------ o_ec __ es_ y DMN0 Liver Extract -------------------
and Fraction Ll 
The r elease of low molecular weight mate~i·a1 ... from dialysis 
sacs over a period of six hours is displayed in figure 3 .14. 
The dialysis sacs containing 100 mg. of a liver extract 
f rom DMNO treated rats released low molecular weight material at 
a slow steady rate. The additi on of trypsin to the liver extract 
caused a large increase in the rate of release of this material, but 
trypsin alone did not release any appreciable quantities of dialysable 
material . 
Fraction 11 underwent a process of self degradation 
releasing large quantities of dialysable molecules. The rate of 
release of molecules by fraction 11 was greater than that of the 
crude extract, but this may be due to a concentration effect. Trypsin 
again greatl y enhanced the release of dialysable material. 
3,4.5 !}2~_Release_of_Dialysable Molecules_by_Frection_Ll_in_Vivo 
and their Imnortance in its Anti -inflammatoE:Y Action ____________ c ___________________________ __ __ --- ---· 
The effect of the subcutaneous implantation of dialysis 
sacs in vivo on carrageenan induced oedema in the rat is shown in 
f igure 3.15 . 
Dialysis sacs f i lled with saline alone are anti-inflammatory 
(p ( o. 05 ) when compared to the sham operated controls as are dialysis 
sacs containing 100 mg. of fraction Ll and 10 mg. of trypsin 
(p <. 0.025 ). 
There was, however, a significant difference (p< 0,05) 
between these two groups indicating that material released by the 
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Figure 3. 14 The Release of di al ysable substances (as measured by 
absorbance ) from di alysis sacs containing:-
100 mg . Li ver extract from DMN0 treated rats • - • , 
100 mg . Liver extract from DMN0 treated rats and 5 mg. of 
trypsin □-□, 
100 mg of fraction 11 0--0, 
100 mg of fract i on 11 and 5 mg . of trypsin ¥,-¥, 
and 5 mg . of trypsi n alone 0-0. 
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Figure 3.15 The effect of carrageenan induced oedema of implanted 
dialysis sacs containing saline alone 0 - 0 and 100 mg. of 
fraction 11 and 10 mg. trypsin •-• compared to sham 
operated controls◊-◊ . 
Each result represents the mean of seven ani mals+ SEM . 
91 
3.4.6 The Role of Oligoamines in th M • 
----------------------------~--~~~~~;~~of Action of DMNO 
Liver Extracts ----------------
Table 3.6 shows the levels of putresci ne and 
cadaverine found in liver extracts from nonnal a"d ONOtreated rats . 
The levels of both putrescine (p < o 001) a d d · . n ea averi ne 
(p < 0. 001) are significantly higher in the liver extracts from the 
DMNO t reated animals. 
TabJ.d 3. 6 
Treatment µg cadaverine per µ g of put resci ne per 
.ldO .mg •.. dry .weight . . . 100 .mg . . dry weight . 
NORMAL 26.22 + - 0.05 9.28 + 0.53 -
DMNO 576.69 + - 44.43 519.98 + 39. 62 -
The levels of spermine and spermidine wer e also determined 
i n these two liver extracts and the results are shown i n table 3. 7 . 
Table 3.7 
Treatment ll g spermine per µ g spermidine per 
50 mg. dry weight 50 mg. dry weight 
NOR.'1AL 8.45 + 0.49 4.46 + 0.33 - -
DMNO 4.15 + 0.97 6.32 + 1.04 - -
Although the levels of spermidine are elevated by 
treatment with DMNO the result is not statistical ly significant . 
Sper mine is significantly higher (p< 0.01) i n normal liver extracts. 
The dialysate of a DMNO extract (100 mg . ) al one and of 
DMNO extract (100 mg,} plus trypsin (10 mg.) were examined for the 
d Cadaverine , the r esults are shown in presence of putresci ne an 
table 3.8. 
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Contents of µg cadaverine per µg putrescine 
Dialysis sac cm3 of dialysate per cm3 of dialysate . ....... 
DMNO 34.09 + 3.98 EXTRACT - 22.12 + 1.21 -. . . . . . . . . . .......... . . . . . . . 
DMNO 
EXTRACT + 40.09 + 2.78 22.50 + 1.94 -TRYPSIN -
. .. .. ' . . . . . . 
Table 3.8 
The effects of trypsin on the release of cadaverine and 
putrescine are not significant. Table 3.9 shows the levels of the 
other polyamines spermine and spermidine in dialysates. 
Table 3. 9 
Contents of µg3spermine per µg spermidine per 
Dialysis sac cm of dialysate cm3 of dialysate 
DMNO 
EXTRACT 0. 96 + 0.68 3.54 + 0. 34-- -
DMNO 
EXTRACT + 0.85 + 0.28 4-.52 + 0.32 - -TRYPSIN 
From the data presented in table 3.9 trypsin has no 
significant effect on the release of spermine and spermidine from 
a DMNO liver extract. 
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3.5 The Anti- inflammatory Prope t· f r ies o Sponge Induced Inflammatory 
Exudate 
3.5.1 The_Fractionation_o~_§E~~g~_Exudate_by Gel filtration 
------------
The elution profile obtained when sponge exudate was 
fractionated on a Sephadex G-150 column (100 x 2.5 cm.) 1· 5 illustrated 
in figure 3.16. The fractions were pooled with reference to this 
profile to form two new fractions Sl and S2 . 
3.5. 2 The_Effect_of_S~onge_Induced_Inflammatory Exudate and 
--- ------------
Fractions_Sl_and_S2_on_Acid Phosehatase Release from 
-- -----------~-------
Figures 3.17, 3.18 and 3.19 illustrate the effect of 
sponge induced inflammatory exudate and fractions Sl and S2 upon 
the percentage release of acid phosphatase from macrophages. Figure 
3.17 indicates that the unpurified exudate significantly inhibits the 
release of acid phosphatase at all the concentrations used. 
-3 
However, at a concentration of 100 mg.cm of exudate there is a 
significant (p<0 . 005) decrease in the inhibition of acid phosphatase 
release. Figure 3.18 shows that fraction Sl significantly inhibits 
-3 
the release of acid phosphatase upto a concentration of 50 mg.cm 
of exudate. Above this concentration the inhibition rapidly 
decreases and at 100 mg.cm-3 of exudate lysis of the cells is quite 
pronounced. 
Fraction S2 exhibits similar properties to Sl (see Figure 
3.19}, but, as can be seen the range over which S2 exerts an inhibitory 
effect is quite small. Jndeed at concentrations greater than lO mg. 
-3 · d or completely cm the inhibitory effects are either decrease 
abolished, that is, a lytic effect is exerted. 
94 








100 180 260 340 420 500 
Elution 
Volume (cm3) 
Figure 3.16 The protein elution p~ofile of inflammatory exudate 
through a Sephadex· G-150 column in O,SM saline. The 
absorbance at 280 nm. of the eluted proteins was measured. 
Fractionspooled are indicated by Sl and S2. 
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Figure 3.17 The effect of inflammatory exudate on the percentage 
release of acid phosphatase from macroph_ages. 
Each resul t represents a mean of four observations~ SEM, 
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Figure 3 .18 The effect of fraction Sl on the release of acid 
phosphatase from macrophages. 
Each result represents a mean of four observations~ SEM. 
97 










· p<O. 025 
50 
C onc t:ntr at ior: 
(me cnt 3) 
Figure 3.19 The effect of fraction S2 on the release of acid 
phosphatase from macrophages. 
Each. res.ul t represents a mean of four observations + SEM. 
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3.5.3 
Inflammatori Exudate ----------- --------
Plates 1 to 4 show the results h 
w en the antisera raised 
against sponge induced inflammatory exudate and lysosomal membranes 
Pre-incubated with this exudate are reacted ... 1·th . ( " antigens normal 
rat plasma, sponge induced inflammatory exudate) using the 
imrnunoelectrophoretic technique. For meth d 
o s see sections 2.4.1, 2.4.2 
and 2.4 .3. From plates 1 and 2 it can be seen that when using 
sponge exudate as antigen and anti-sponge exudate as antiserum between 
4 and 6 proteins are detected which is similar to when normal rat 
plasma is used as antigen. Plates 3 and 4 are identical to plates 
1 and 2 except, in this case, the antiserum is anti-lysosomal 
membrane/sponge exudate pre-incubation. The same pattern is produced 
for an antigen of normal rat plasma or sponge exudate, that is between 
4 and 6 proteins. 
If either antisera is first reacted with normal rat 
plasma no proteins can be detected using these modified antisera and 
the antigens normal rat plasma and sponge induced exudate. 
3.5.4 The_Proteinase_Activity_of_SEonge_Induced_Inflamrnatoi1 
Exudate 
When 10_0 mg. of sponge exudate (adrenalectomised donor 
rats ) was incubated with Azure blue hide powder at 37°C, in O.OSM 
. f th substrate was broken down in tris buffer, pH7.4, 0.617 mg. o e 
the twenty four hour assay period. 
When· compared with pooled .human rheumatoid synovial 
(3 02 mg in 24 hours), but the fluid this activity is below average • • 
.·. . able amount of proteolytic sponge exudate has a low, but appreci 
activity . 
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Plate Antigen - Normal Rat Plasma . 
Antiserum against sponge induced inflammatory exudate. 
4 
n 
Plate 2 fl tory exudate. Antigen - Sponge induced in amma 
Antiserum - as in Plate 1. 
100 
Plate 3 . Antigen - Normal Rat Plasma . 





try Exudate . Plate 4 . Antigen - Sponge Induced Inflamma 0 
Antiserum - as above in Plate 3. 
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3_5.5 ~~~_Self-digestisn_~f-~Eong~-!~~~~~~- Inflammatory_Exudat_ 
I n Vitro --------
Figure 3. 20 displays the release of low molecular weight 
material from dialysis sacs over a period of six hours. Th dialy i 
sacs containing inflammatory exudate alone released low molecul r 
weight fragments at a slow steady rate. The addition of trypsin to 
the exudate caused a large increase in the r ate of release of 
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Figure 3 . 20 The Release 0£ low molecular weight fragments (as measured by Absorbance) from dialysis sacs 
containing inflammatory exudate alone •-• , inflammatory exudate and trypsin 0 , and trypsin alone 
o-o. 
3.5.6 The Release of Dialvsabl M • 
-------------------~ e olecules in Vivo b S ---------~~--------------Y __ 2ons~ 
Induced_Infla~!~~ Exudate --------
Figure 3.21 shows the effect f . o implanted dialysis bags, 
containing varous substances on carrageenan 
rats. 
induced oedema in 
As can be seen the dialysis hags alone were not anti-inflamm-
atory, but the hags containing inflannnatory exudate alone exerted an 
anti-inflammatory effect, the significance at the six hour measure-
ment being p < 0. 05. 
The dialysis bags containing trypsin alone and trypsin plus 
inflammatory exudate were not significantly anti-inflammatory. 
3.5 .7 The_Anti-inflammatory_Activity_of_SEonge_Exudate_Dialysate 
The dialysate from a sac containing sponge induced 
inflammatory exudate collected . in vitro was used in a carrageenan 
oedema test . The results from this experiment are shown in figure 
3.22. A dose of 1 cm3 of the dialysate given intraperitoneally· 
one hour before the carrageenan was significantly anti-inflammatory 
at six hours afterwards ( p <. 0. 05). A daily subcutaneous injection 
of 0.1 cm3 of the dialysate starting ten days prior to the carrageenan 
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fj gure 3.21 The effect on carrageenan induced oedema of implanted 
dialysis bags containing inflammatory exudate alone •-• , 
inflammatory exudate and trypsin ¥-¥, trypsin alone □-□, 
and saline ,alone 0-0, Sham operated controls are also 
shown◊-◊· 
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figure 3.21 The effect on carrageenan induced oedema of implanted 
dialysis bags containing inflammatory exudate alone •-• , 
inflammatory exudate and trypsin )f-¥, trypsin alone □-□, 
and saline alone O-O, Sham operated controls are also 
shown◊-◊· 
Each rest.µts represents the mean of six ani mals + SEM 
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~igure 3,22 The effect on carrageenan induced oedema of a single 
dose of sponge exudate dialysate •-• and a multiple 
dose of dialysate 0--0, compared to untreated controls o-o. 
Each result represents the mean of seven animals+ SEM. 
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3.5.8 The Irritancy of Snonge Id d Ex · ------------------C--Q---~-~s~ ____ udate_Dial~sate 
The sponge exudate dialysate used in the previous 
experiment was also tested for its irritant activity. The results 
from this experiment are shown in f' 3 23 igure .. 
This dialysate was three times as irritant as saline at 
t hree and six hours after injection . 
3.5.9 The_Anti-inflammato~_and_Irritant_Activit~_of_SEonge_Exudate 
after_Dialysis 
The sponge exudate left after ten days of dialysis in vitro 
was tested for anti-inflammatory activity using the carrageenan 
oedema model. The results are shown in figure 3. 24 
This residue after dialysis was anti-inflammatory at 
three hours after injection of the carrageenan , but it was not 
significantly anti-inflammatory at six hours . 
-3 The irritancy of the solution used (100 mg . cm ) was also 
investigated and these results are shown in figure 3 . 25. The 
solution was three times as irritant as saline at both three and six 
hours after injection. 
W1 
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Figure 3.23 Increase in foot yolume of rats injected with sponge 
exudate dialysate •-• compared to controls injected with 
saline alone o-o. 
Each result represents the mean of seven animals+ SEM. 
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Figure 3.24 The effect on carrageenan i nduced oedema of dialysed 
sponge exudate•-•, compared to saline treated controls 
o-o. 










Time ( h) 
Figure 3.25 The increase in foot yolume of rats injected with 
dialysed sponge exudate•-•, compared to controls injected 
with saline alone 0 - 0. 
Each result represents the mean of six animals+ SEM. 
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· 3.5.10 The_Levels_of_Olig~~~~~~s_in_SEonge_Exudate_and_SEonge 
Exudate_Dialysate 
The following levels of oligoamines were found in 100 mg. 
dry weight of sponge exudate:-
putrescine 6.76 + 0 . 65 µg -
cadaverine 19 . 60 + 0 . 14 µg -
spermine 17.60 + 3.91 µg -
spermidine 12 . 70 + 1.10 µg -
The dialysate of sponge exudate (100 mg.} alone and 
of sponge exudate plus trypsin (100 + 10 mg.) were examined for the 
presence of putrescine, cadaverine, spermine and spermidine, the 
results are shown in table 3.10. 
Table 3. 10. 
Amount of ol igoamines SPONGE SPONGE EXUDATE 
.per cmq di al ysate EXUDATE -t TRYPSIN 
µg putrescine 4.21 + 0.03 5.43 + 0. 82 -
µg cadaverine 16.19 + 0.18 17.18 + 0.19 -
µg spermine 1.69 + 0 . 56 1.16 + 0 . 44 - -
µg spermidine 3.03 + 0 . 49 3.46 + 0.19 -
From table 3.10 trypsin has no significant effect on 
the levels of putrescine, spermine and spermidine found in the 
dialysate . The level of cadaverine, however, is significantly 
elevated ( p < 0. 005). 
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3.6 The Role of Oligoamines in Inflammation 
3 . 6 . l The _Anti-inflarnmatori_Action_of_Oligoamines_on_Carrageenan 
Induced Oedema 
The effect of carrageenan induced oedema of the four 
oligoamines spermine, spermidine, cadaverine and putrescine at dose 
levels of 50 µg, 500 µg and 5000 µg per Kg. body weight are shown 
in figures 3.26, 3,27, 3 . 28 and 3.29 respectively. 
Spermine (figure 3.26) shows no significant difference 
·from the sali ne treated controls at any of the doses used. 
Spermidine (figure 3.27} at 50µg per Kg depressed swelling, 
but the r esult was not statistically significant. When the dose 
was increa sed to 500 µg per Kg . a greater degree of inhibition of 
oedema was observed, the five hour measurement being significant 
(p <. 0 . 05} . A dose of 5000 µg per Kg . was significantly anti-
inflammatory at both three ( p < 0 . 05) and five (p < 0. 05) hours. 
Cadaverine exhibits slight anti-inflammatory activity. 
This activity is not dose related and the only statistically 
s i gnificant point is the three hour (p < 0 .05) measurement using a 
dose of 50 µg per Kg. 
Putrescine was intensely anti-inflammatory against carra-
geenan induced oedema. At all the doses used, at both three and 
five hours after injection of the carrageenan, oedema formation was 
s i gnificantly inhibited. 
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Figure 3 , 26 The effect on carrageenan induced oedema of spermine 
given intraperitoneally at doses of 50 µg per Kg • - • , 
500 µ g per Kg. :+- :+ and 5000 µg per Kg □-□. Saline 
treated controls are also shown 0-0 . 
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Figure 3.27 The effect on carrageenan induced oedema of spermidine 
(ip) at doses of 50 µg per Kg •-•, 500 µg per Kg Jf--¥-, 
and 5000 µ g per Kg 0-0 compared to saline treated controls 
o- o . 
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Figure 3.28 The effect on carrageenan induced oedema of 
cadaverine at doses of 50 µg per Kg •- •, 500 µg per Kg 
)f-'f and 5000 µg per Kg 0--0 compared to saline treated 
controls 
Each result represents the mean of seven animals+ SEM . 
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FigllI'e 3,29 The effect on carrageenan induced oedema of putrescine 
at doses of 50 µ g per Kg •-•, 500 µ g per Kg ¥-¥ and 
5000 µ g per Kg □-□ compared to saline treated 
controls 0 - 0 . 
Each result represents the mean of seven animals+ SEM. 
116 
3.6.2 The_Irritant_Proeer~~~~_of_Oligoamines 
The solutions of oligoamines at concentrations of 10 µ g, 
-3 
100 µ g and 1000 µ g cm as used in the previous experiment were 
tested for their irritancy by injecting them into rats feet and 
measuring the resultant oedema. The results of this test are 
displayed in figures 3.30, 3.31, 3.32 and 3.33. 
Spermine (figure 3.30) was not significantly irritant 
-3 . at either 10 µg or 100 µg cm concentration. Spermine at a 
3 
concentration of 1000 µg cm was significantly irritant when compared 
to saline . 
Spermidine (.figure 3. 31) was not irritant at either 10 
- 3 
or 100µ g cm At 1000 µg cm-
3 spermidine was irritant after three 
hours , but not significantly irritant after five hours. 
Cadaverine (figure 3.32) was not irritant at any of 
the doses used. 
Similarly putrescine (figure 3.33) showed no significant 
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figure 3.30. Increase in foot volurpe of rats following injection 
of spermine at 
-3 
10 µ g cm •-• 
-3 
100 µ g cm ¥--¥-, 
-3 and 100~ g cm □-D compared to saline treated controls 0 - 0 . 
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figure 3.31 Increase in foot yolume of rats following injection of 
spermidine at 10 µ g cm-
3 
•- •, 100 µ g cm-
3 
)f.-)f. and 
-3 100~ g cm □-□ compared to saline treated controls 0--0. 







Figure .3. 32 Increase in foot 
cadaverine at lOµgcm 
-3 
-3 
cm □-□ compared to 
p <. 0 . 05 I 
3 5 
Time (h) 
yolume of rats following injection of 
•-•, 100 µg cm -3 "f.-¥, and 1000 µg 
saline treated controls 0 -0. 
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Figure 3.33 Increase in foot volume of rats following injection of 
-3 -3 
putrescine at 10µ g cm •-•, 100µ g cm ¥-¥ and 
-3 
1000µ g cm □-□ compared to saline treated controls 0-0 . 
Each result represents the mean of five animals+ SEM . 
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3.6.3 The Effect of 0lit10 · p · · -----------------~-~~~~~_on __ innal_'!!~ehilaxis in the Mouse - ------------------
The effect upon the development of a local anaphylactic 
reaction in the mouse pinna was · · investigated using doses of 50 µg per 
Kg of the oligoamines spermine, sperm'd'ne, d · d · • • ea averine an putrescine. 
The results are shown in table 3.11. 
Table 3:11 
Diameter of dye Diameter of dye 
release at 30 release at 60 
mins. mins. 
Controls 23. 20 + 3.83 26.40 + 3.17 - -
Putrescine 22.2 + 1.96 24 .60 + 1. 72 - -.. . . 
Cadaverine 20.0 + 2.24 24.2 + 2.76 - -.. . . . . 
Spermine 19.4 + 2.60 21.4 + 1.96 - -
Spermidine 21.4 + 3.31 25.00 + 4.63 - -
From this table it can be seen that none of the 
oligoamines tested had any effect on the development of the local 
anaphylactic reaction produced in the mouse pinna. 
3.6.4 The_Stabilization_of_Guinea_Pig_MacroEhages_b~_0lisoamines 
Solutions of spermine, spermidine, cadaverine and putrescine 
-3 
at concentrations of 10 µ g, 100 µ g, 1 mg. and 10 mg. cm were tested 
for their ability to stabilize guinea-pig macrophages. 
Figure 3.34 shows the effect of spermine on these cells. 
In this case spermine had no effect at the concentrations used. 
Spermidine (figure 3.35) exhibits contrasting effects at different 
concentrations. At the lower concentrations used it ~as lytic while at 
the highest dose spermidine had no significant effect. Cadaverine 
(figure 3.36) had no effect at the lower concentrations used1 but 
122 
had a stabilizing effect at the highest concentration used. 
Putrescine (figure 3. 37) behaved in the same fashion, that is 
it had no effect at the lower concentrations but stabilized at 
the highest concentration used. 
U3 
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Figure 3.34 The effect of spermine on the release of acid 
phosphatase from macrophages. 
Each result represents the mean of four observations 3 SEM. 
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Figure 3.35 The effect of spermidine on the release of acid 
phosphatase from macrophages. 
Each result represents the mean of four observations~ SEM . 
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Figure 3.36 The effect of cadaverine on the release of acid 
phospt,atase from macrophages. 
Each result represents the mean of four observations+ SEM. 
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Figure 3. 37 The effect of putrescine on the release of acid 
phosphatase from macrophages. 
Each result represents the mean of four observations+ SEM . 
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3.6.5 The Anti-Inflammatory Action of Putrescine in the Ad;uvant - - -------------------------------------'-----
Arthritic Rat 
The effect of daily subcutaneous injections of 50 µ g and 
500 µ g per Kg of putrescine upon the development of adjuvant 
arthritis in the rat may be seen in figures 3.38 and 3.39. Figure 
-
3.38 shows the mean increase in foot volume of the foot injected with 
adjuvant on Day 0. From this figure it can be seen that a daily 
-1 
dose of 50 µg Kg of putrescine was anti-inflammatory (p( 0.05). 
-1 A daily dose of 500 µg Kg . of putrescine was ineffective. 
The increase in foot volume of the non injected foot is displayed 
in figure 3.39. A similar situation occurs in this case, the lower 
dose being significantly anti-inflammatory (p< 0.05) while the higher 
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Figure 3.38 The effect on the injected foot volume of adjuvant 
arthritic rats given daily injections of putrescine at doses 
1 -1 
of 50 µ g Kg - .,_ • and 500 µ g Kg 'f-'f compared to saline 
treated controls 0-0. 
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Figure 3.38 The effect on the injected foot volume of adjuvant 
arthritic rats given daily injections of putrescine at doses 
l -1 
of 50 µ g Kg - -•- • and 500 µ g Kg ¥-- )f. compared to saline 
treated controls 0-0. 











Figure 3.39 The effect on the non-injected foot volume of adjuvant 
arthritic rats given daily injections of putrescine at doses 
1 -1 
of 50 µ g Kg - • - • and 500 µ g Kg 'f-'f compared to saline 
treated controls o-o • 
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Figure 3. 39 The effect on the non-inject ed foot volume of adjuvant 
arthritic rats given daily injections of putrescine at doses 
1 -1 
of 50 µg Kg- •- • and 500 µg Kg ¥-¥ compared to saline 
treated controls o-o • 
Each result represents the mean of six ani mals+ SEM. 
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3.6.6 The Effect_of_~~~~hilline and Thi.oceetamide on 
- -------------------------
Carrageenan_Oede~~ 
The effect of a single dose of thioacetamide (150 mg Kg-1 ) 
given intraperitoneally 24 hours before the injection of carrageenan 
may be seen in figure 3.40 . At both three and five hours after 
injection of the carrageenan thioacetamide treatment significantly 
inhibited the oedema formation. Figure 3.40 also shows the effect 
of a daily oral dose of theophylline (15 mg Kg-1 ) started two days 
prior to the test. The results show theophylline is anti-inflammatory 
although only the three hour measurement is statistically significant. 
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figure 3. 40 The effect on carrageenan i nduced oedema of thioacetamide 
•- • and theophylline 'f-'f compar ed t o saline controls 0 - 0 . 
Each result represents the mean of s even ani mals! SEM . 
132 
·3_7 ·Toe ·Role ·of Endoto.xin in Inflammat i on 
3.7.1 The_Anti- inflamrnatori Effect of Endotoxin 
-- --------------------
The anti-inflanrrnatory effect of bacterial endotoxin, 
given intraperitoneally, on the development of carrageenan oedema is 
shown in figure 3. 41. A dose of 5 µ g Kg -l i s not anti-inflammatory 
-1 
while -a dose of 20µg Kg is anti-inflammatory at three hours , but 
not at six hours . -1 The highest dose used, 100 µg Kg , was 
significantly anti-inflammatory at both three and five hours. 
-3 . The irritancy of a 100 µg cm solution of endotoxin was 
a lso evaluated and the results are shown in figure 3.42 . From these 









· p<O. 001 
6 
Time (h) 
figure 3. 41 The effect of carrageenan induced oedema of an intra-
peritoneal injection of bacterial endot()](in at doses of 
~ ~ l Sµg Kg •-•, 20 µg Kg 'f-'f and 100 µg Kg- 0---0 
when compared to saline treated controls 0 - 0 . 
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Figure 3.42 The increase in foot volume of rats following injection 
-3 
of a solution of endotoxin (100 µg cm ) •-• compared to 
saline treated controls 0-0. 
Each result represents the mean of seven animals+ SEM. 
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3.7.2 The_Degree_of_Stabilization of Guinea Pi 
----------------------- Macro ha es 
by Endotoxin 
Figure 3.43 demonstrates the effect of bacterial endotoxin 
at concentrations of 100, 50, 10 and l µg cm-3 on the stability 
of guinea-pig macrophages. From this figure endotoxin does not 
stabilize the cells, in fact, at concentrations of 1 , 50 and 100 µg 
3 
cm it is significantly lytic. 
3.7 .3 The_Levels_of_Oligoamines_in_Bact erial_Endotoxin 
Bacterial endotoxin used in the preceding experiments 
was assayed for sperrnine, spermidine, putrescine and cadaverine 
and the results are presented in table 3.12 . 
'Table 3.12 
µg of polyarnine in 
25 mg of Endot oxin 
Spermine 1.24 + 0.35 -
Spermidine 3 . 58 + 0 . 37 -
Cadaverine 40.22 + 2.11 -
Putrescine 8 . 78 + 0. 68 
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C -3 oncentrat i on (µg . cm) 
Figure 3.43 The effect of endoto.xin on the release of acid 
phosphatase from macrophages . 
Each result represents t he mean of eight+ SEM. 
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4. DISCUSSION 
4 .1 The Evaluation of the Proteinase Inhibitor Trasylol as a 
Potential Anti-Inflammatory Agent 
The effectiveness of Trasylol as an anti-inflammatory 
agent has been the subject of a controversy for some time. The use 
of animal mod 1 t e s O test the anti-inflammatory activity of Trasylol 
has generally been confined to those representing the acute phase 
of the inflammatory Teaction (Forster , 1969; Spilberg and Kirk-
Osterland, 1970). The activity of Trasylol in acute inflammatory 
conditions could be expected since it inhibits kallikrein which is 
necessary in the formation of the inflammatory mediators known as 
kinins which are of importance during the early phase of inflammation . 
In this investigation the use of chronic animal models has 
clearly demonstrated that Trasylol was unable to reduce the formation 
of granulation tissue around implanted cotton wool pellets. Further-
more, Trasylol, when tested against the adjuvant arthritic rat, was 
ineffective in suppressing the inflammation and at the doses used was 
pro-inflammatory after day 12 of the experiment. The failure of 
Trasylol in the chronic animal models used may be a reflection of its 
inability to act against the inflammatory processes involved in the 
later stages of the syndrome such as the deposition of granulation 
tissue . The use of Trasylol in the treatment of rheumatoid 
arthritis stems from the suggestion that it is capable of inhibiting 
acid and neutral proteinases released from polymorphonuclear 
leukocytes during the inflammatory reaction (Spilberg and Kirk-
Osterland, 1970). Further support for this theory is offered here 
Clearly inhibit the proteolytic activity of human since Trasylol can 
rheumatic synovial fluid samples in vitro and because of its low mole-
cular size its passage to the site of inflarmnation would be easier . 
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The clinical use of T 
rasylol in rheumatoid arthritis has met with 
varied results, but its use a . 
s an intra-articular preparation may be 
of benefit (Bruckner and Eisen 1970 . M L , , arcy , oyau, and Dumas, 1972). 
4.2 . Th L 
e · evels of Proteinases and Anti-proteinases in Human Rheumatic 
·synovial ·Fluid Samples 
The levels of alpha-1-antit:rypsin in sera and synovial fluid 
from patients with rheumatoid arthritis and other joint diseases 
have been found to be significantly elevated (Brackertz, Hagmann 
and Kueppers, 1975; Swedlund, Hunder and Gleich, 1974). It was 
suggested by these workers that higher than normal concentrations 
of alpha-1-antitrypsin could help to control tissue damage by 
inhibiting the proteolytic enzymes released from the lysosomes of 
polymorphonuclear leukocytes which are thought to be responsible 
for the degenerative processes occurring . Experimental support 
for this view may be offered by the results presented here since a 
significant correlation between alpha-1-antitrypsin levels and 
proteinase levels in rheumatic synovial fluids was obtained. This 
data is consistent with the concept that alpha-1-antitrypsin may 
help to regulate joint inflammation by inhibiting the proteolytic 
enzymes which attack joint tissues. Significant positive correlations 
were also obtained between proteinase and total protein and alpha-2-
macroglobulin and total protein levels. These correlations probably 
reflect the general increase of protein levels within the joint due 
to both tissue breakdown and extravasation of proteins from the 
surrounding tissues into the joint capsule. 
4.3 The Role of Endotoxin in Inflammation 
Smith, Ford-Hutchinson and Walker (1977) have stated that 
endotoxin contamination of anti-inflammatory factors isolated from 
natural sources may cause spurious results . 
These workers base their theory on the growth of gram-negative 
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bacteria in the column packing material (Sephadex) which on 
application of hypertonic samples are lysed and endotoxin (LPS) is 
released. The LPS then behaves as a low molecular weight material. 
in the separation rather than its true molecular weight c~ 200,000). 
This explanation may be possible since hypertonic solutions 
would cause cell death and destruction, releasing LPS, but actual 
lysis of the cells is unlikely. The sample used in this fractionation 
was unusual because it had been derived from hUl'llan plasma using the 
techniques of ultrafiltration and concentration which had the 
effect of concentrating the sample fifty times and thereby greatly 
increasing the tonicity {Ford-Hutchinson , Insley, Elliot, Sturgess 
and Smith, 1973). In comparison the materials investigated in this 
project were either dissolved in or equilibriated with elution 
buffer prior to application to the column . The samples did not 
contain an excess of inorganic ions and the contribution of the 
higher molecular weight molecules to the overall osmotic pressure should 
be relatively small. The change in tonicity on addition of the 
sample should, therefore, be minimal . These workers also found that 
-1 a dose of 2µ gKg of LPS was anti-inflammatory when given 
intravenously to rats used in a carrageenan induced paw oedema test. 
The results from the present study indicate that when given by the 
intraperitoneal route (the method utilized for the injection of all 
test materials) LPS was much less effective in reducing inflammation. 
For this investigation the stabilization of monocytes was 
studied since these cells are considered to be important in the 
inflammatory process (Lack, 1969). This model was chosen in 
preference to the stabilization of lysosomes (Hempel, Fernandez 
and Persellin, 1970; Persellin, Vance and Peery, 1974) since, as 
Ignarro (l971) pointed out, that model suffers the disadvantage that 
· t 1 condi'tions can lead to different results . different experimen a 
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For comparative purposes LPS was test d . h ' e in t is manner and was 
shown to have lytic pr oper ties when incubated with guinea pig 
macrophages · which has important consequences for SOlDe of the work 
t o be discussed later. LPS ms al,,r=s l:ee.n slmn to t · · 
~ con ain spermine , 
spermidine, cadaverine and putrescine , some of which are 
markedly anti-i nflammatory (see later ) and may account , at least 
in part, for its anti-inflammatory activity. 
The problem of endotoxin contaminat i on still exists and 
i s of importance since Maguire and Wallis (1977) found exclusion 
of bacteria from the fractionation of anti-lymphocyti c serum 
abolished the anti-inflammat ory activity of one of the fractions . 
The reasons why LPS should be anti-i nflammatory remai n 
unsolved, but its effects are wi de ranging and several features may 
be important. Endotoxin has been shown to cause changes in vascular 
perrneability,neutrophil chemotaxis and release of vasoactive 
substances, including histamine and kinins. I t also causes an 
i ncrease in serum 11-hydroxycorticosteroid concentration (Munoz , 1961} 
and activation of the complement system (Bladen, Gewurz and 
Me_rgenhagen, 19.6 7 L 
One of t he other problems associated wi th the study of 
endogenous anti- inflammatory substances is the counter irritation 
theory . Although the pr obl em has not been attacked directly in this 
investigation it has been consi dered. Thus all t he compounds tested 
for anti-inflarmnatory acti vity have also been assayed for their 
• · t t · and an evaltation of both activities should provide an irritan ac ion 
· h th the anti ~i nflaromatoT'V activity is due to counter answer tow e er -~ 
irritation or not. 
The Role of Oli goamines in Inf lammat i on 
Although ol i goamines possess some properties that may be 
relevant to inflammation, for example putrescine may be involved in 
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the production of ant i -inflammato-mr mediators, 
-J until recently there 
has been no evidence of t heir direct involvement in the inflannatory 
process. In this investi gation the direct anti-inflammatory 
activity of spermine ,_ spermi·di·ne, d 
ea averine and putrescine has 
been studied. 
Using the car r ageenan induced oedema of the rat foot as a 
test model spermine was not anti- inflammatory, similarly cadaverine 
exhibited very little activity. Spermidine was anti-inflammatory 
and an approximate dose dependant relationship was observed . 
Putrescine was intensely anti-inflammatory at all the doses used , 
but this effect was not dose r elated. 
The irritancy of the solutions u~ed in the above test 
was not related to the anti-i nflammatory activity . Both 
cadaverine and putrescine were not irritant. Spermine was irritant 
at the highest dose used and spermidine was also mildly irritant 
at the highest dose level . 
None of the ol igoamines had any effect on the development 
of a local anaphylactic reacti on in the mouse ear. 
The in vitro test of anti-inflammatory activity 
involving the incubat i on wit h guinea-pig monocytes and measuring 
t he stabilizing effect of the oligoamines was also used. In this 
case a distinct difference was noted between the diamines putrescine 
and cadaverine which have some stabilizing effects and the polyamines 
Whl..ch had no effect and spermidine which had either no spermine, 
effect or was lyt ic. 
Putrescine was also evaluated using the adjuvant rat model. 
In this case putrescine inhibited the development of the primary 
l.·nflammatory lesions, an increase in dose negating this and secondary 
effect. 
· cadaveri' ne, spermidine and putrescine all In conclusi on 
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possess some degree of direct .. 
anti-inflammatory act ivity which 
does not appear to be related t h 0 t eir irritancy. In addition, 
putrescine had a marked effect on h 
t e chronic inflammatory process. 
The reason for a negation of thi·s f e feet by increasi ng the dose is 
unknown , but it may well be a fl re ection of putrescines toxicity since 
it was noted that granulati·on t· issue formed around the site of 
injection in the higher dose while no such problem occurred in the 
l ower dosed group. It must be noted, however, that the dose used 
was far below those which have been found to be non-toxic to rats 
when administered acutely. A more likely explanat ion may be that 
the increase in putrescine triggered the production of ODC antizyme 
thus synthesis of putrescine within the body is slowed down . Some 
evidence is available to support this view (Heller and Canellakis , 
1980) since Nl8 neuroblastoma cells were found to increase ODC 
antizyme production when incubated in a putrescine containing 
medium. This effect was only observed above a certain threshold 
level of the diarnine. 
The mechanism by which putrescine and the ot her oligoamines 
operate is unknown, but from these results they have little effect 
on monocytes or on the anaphylactoid type of reaction . However , it is 
possible that either putrescine itself is an anti-inflammatory 
mediator or it may be involved in the production of anti-inflammatory 
mediators . (Bartholeyns, Fozard and Prakash, 1980) . 
The effects of thioacetamide and theophylline also confirms 
the role of ODC and oligoarnines in inflammation. These compounds 
are known to increase the levels of ODC in the l iver1 thus the 
general levels of oligoamines and particularl y putrescine would be 
elevated. The use of theophylline, an i nhibitor of phosphodiesterase, 
Possibi·1i·ty of the i nvolvement of cyclic AMP in this also raises the 
process . The involvement of cyclic AMP in putrescine biosynthesis is 
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Oli goamines -------~ 
Thus the involvement of cyclic AMP is clear and in 
addition an excess of putrescine would not only result in production 
of antizyme, but would ultimately switch off ODC synthesis . 
finally, prostaglandins may play some part in ODC induction 
(Verma, Rice and Boutwell, 1977), t hus these mediators , which are 
produced during the . inflammatory process , may cause an elevation of 
putrescine · biosynthesis with a resultant anti-inflammatory effect . 
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4.5 The Anti-Inflammatory Activity of Human Rheumatic 
·synovial ·r1uid Samples 
The sample of human h r eumatic synovial fluid used for the 
initial tests of anti-inflammatory and 1.' rr1.'tant activity was 
chosen because of its low proteinase levels and high alpha-1-
antitrypsin levels. 
These results demonstrate that th' is synovial fluid sample 
was anti-inflammatory in the acute model of the carrageenan induced 
oedema of the rats foot at the dose used which was equivalent to 
105 mg. of protein. This synovial fluid had no effect, however, on 
the formation of granulation tissue around implanted cotton wool 
pellets. It should be noted that the synovial fluid had no 
significant irritant activity when compared to saline. It would, 
therefore, seem unlikely that the human rheumatic synovial fluid 
exerted its anti-inflammatory effect by way of the counter irritant 
mechanism. Synovial fluid aspirated from rheumatic patients is 
known to stabilize rat liver lysosomes in vitro (Lewis, Capstick 
and Cosh, 1975} and that the substances responsible were proteins. 
Lewis (1977) observed that "although proteins stabilizing lysosomal 
membranes have properties that suggest that they may be anti-
inflarnmatory, there is no direct evidence that they have an anti-
inflammatory action against the usual animal models". The observations 
from these experiments may offer some additional evidence in support 
of that statement. 
Pooled human rheumatic synovial fluid, when fractionated 
150 Produced two pooled samples Cfl and F2) with the on Sephadex G- , 
split occurring at about 6300 daltons. Both these fractions significantly 
· d ed oedema of the rat paw. The anti-
inhibited the carrageenan in uc 
inflammatory effect of the higher molecular weight fraction (Fl) 
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could be due to lysosomal stabilizing proteins (Lewis , Cap tick and 
Cosh, 1975) or to proteins with an unknown mode of action . The 
anti-inflammatory activity associated with the lower molecular 
weight fraction (F2} was obviously not due to any of the nonnal pla~ma 
proteins since they are all too large to be present in this fraction. 
Also, because the extract was dialysed it is unlikely that very mall 
molecules, for example steroid, were present. It is possible that 
the active component in this fraction was a peptide or polypeptide . 
Although both fractions were irritant when compared to saline they 
were significantly less irritant than the original pooled rheumatic 
synovial fluid sample which was not significantly anti-inflammatory 
in this experiment. From these results it appears unlikely that 
the counter irritant theory was in operation in this case since 
the anti-inflammatory effects of the fractions and original sample 
did not parallel the irritant activity. 
The implantation of dialysis sacs containing human rheumatic 
synovial fluid had no effect when tested against the carrageenan 
induced oedema of the rat paw, the possibility that the synovial 
fluid was capable of releasing dialysable molecules which were anti-
inflammatory does not, therefore, arise. 
The incubation of pooled human rheumatic synovial fluid with 
guinea-pig rnonocytes demonstrated the lytic activity of the 
unfractionated fluid. Upon fractionation this lytic activity was 
· (Fland F2) were capable of stabilizing lost since both fractions 
the membranes of the roonocytes. Earlier work using synovial fluids 
f luids stabilized lysosomes others were showed that while some 
. and Cash, 1975). Thus the data presented 
lytic (Capstick, Lewis 
d . e origin of the pooled rheumatic ~ea reflection of the ivers here may u 
ub t es present are only effective 
synovial fluid or the lytic s s anc 
above a certain threshold level. 
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4 . 6 The Anti-Inflammatory Acti v1.·ty 
of Liver Extracts from 
Dimethylnitrosamine Treated Rats 
Finals (1973) demonstrated that saline extracts of 
livers from rats t t d 
' rea e with the htpatctoxi.n dimethylnitrosamine two 
to s ix days earlier, could de l~, th 
-J e onset and severity of the 
inf lannnation induced by adjuvant in the rat. It has also been 
shown (Parrott, 1977) that t his extract is also effective in 
s upressing the inflammation induced by the · · · f 1.nJect1.on o carrageenan 
into the foot of a rat. In both cases extracts of normal livers 
wer e ineffective. 
In this study the liver extract from dimethylnitrosamine 
treated rats was fractionated by gel filtration to produce three 
fractions pool ed acc·ording to thei r proteolytic activity. The high 
molecular weight fTaction (> 100 , 000 daltons) was significantly 
anti-inflammatory while the other two fractions were ineffective. 
The irritancy of these fractions paralleled their anti-inflammatory 
activity, the most irritant fraction being the high molecular 
wei ght one. It may be possibl e , therefore, that this high molecular 
weight fraction is not truly anti - i nflammatory, but operates by 
causing counter i rritation. 
Using art •in vitro method it is clear that the high 
molecular weight fraction undergoes degradation, which is enhanced 
by the presence of trypsin. The dialysable molecules released during 
t his process are also demonstrably anti-inflammatory in vivo. The 
actl.·ve subst ances is unknown, but it is possible that nature of these 
Part i n the mechanism of action of DMNO liver oligoamines may play a 
extracts. 
that l i ver damage caused by partial hepa-It is well known 
h carbon tetrachloride produces general tectorny and treatment wit 
concomitant elevation of ODC activity 
tissue regeneration wit h a 
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and oligoamine levels <.s.ee Int d . ro uction). In this case liver 
extracts from DMNO trPated t h - ra s ave greatly elevated levels of 
cadaverine and putrescine, spermine levels are depressed and 
spermidine levels are unchanged. This liver extract is capable 
of releasing all four oligoamines when incubated in a dialysis 
sac although the presence of trypsin does not enhance this release. 
Previous experiments (section 4.4} have shown that oligoamines 
possess anti-inflammatory activity and thus the liver extracts may 
operate via this route and explain the results of Pinals (1973) . 
4. 7 The Anti-Inflammatory Properties of Sponge Induced 
Inflammatory Exudate 
The fractionation of sponge exudate by gel filtration 
confirms the results of Billingham, Robinson and Robson (1969) . A 
possible mechanism of action for the anti-inf l ammatory substances 
f ound in sponge exudate may be explained by its action on monocytes 
in •vitro. The unfractionated exudate was capable of stabilizing 
t he membranes of these cells. On fractionation both fractions (51 
and S2) are capable of stabilizing the cells at t he lower 
concentrations used, but at higher concentrat i ons the fractions were 
lytic . From this it may be concluded that, during fractionation. 
e ither the lytic substances have been concent r ated from the original 
material or they have been introduced by the process . In the case of 
h 1 h 
· ;t may be possible the contamination with 
t e atter hypot es1s ~ 
endotoxin is the reason for the introduction of the lytic compounds 
· precauti'ons were taken during the fractionation 
since no special 
procedure. 
The study of sponge exudate using antisera yielded few 
positive results. 
However, it can be concluded that the major 
d normally found in rat plasma a1s0 
proteins present in the exu ate are 
· adhere to l ysosomes are normal plasma 
the proteins that apparently 
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proteins. These results do not 
preclude the possibility of a 
protein or polypeptide, present 
in low concentration, having anti-
inflammatory capabilities. 
From 'in ·vitro studies f h 0 t e proteolytic activity of this 
inflammatory exudate it · ib 
is poss le to conclude that it posse ses 
inherent proteolytic activity. Th' · · is activity is at a low level 
when compared to rheumatoid synovial fluid , but is sufficient to 
account for the self degradation of the exudate d an the subsequent 
release of dialysable molecules. 
The ·in ·vivo study of these dialysable molecules proved that 
their presence induced a change in the rat such that when the animal 
was later challenged by an inflammatory stimulus the resultant 
oedema was significantly smaller than control animals. There is some 
suggestion from this experiment that trypsin negates this effect. 
This may be because the active component is destroyed by trypsin. 
suggesting that it is a protein, or trypsin accelerates its release 
to leave only low levels when challenged. The use of sponge 
exudate dialysate collected in vitro showed that it was anti-
inflammatory, but this was allied to its irritancy. In addition the 
residue after dialysis was also irritant and anti-inflammatory. 
A possible mode of action for these dialysable molecules 
is suggested by the work of Sarcione and Bogden (1966) who 
demonstrated the synthesis of alpha-2-glycoprotein in isolated 
· d t They argued that, since injury at perfused livers from inJure ra s. 
· t· ulates production of the protein, sites peripheral to the livers uo 
ti· ssues must release a factor into the blood which the injured 
prompts its hepatic synt besis, 
Evidence to support the existence 
· ·t· tor substance or HIS 
of an extra-hepatic factor (humoral ini ia 
d Fuss (1966) who found that 
factor) was provided by Bogden, Gray an 
caused increased synthesis of alpha-2-
serum from injured rats 
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glycoprotein in the liYers fro;n no"'"'al . 
... ,u animals • A mechanism simil 
t o this could account for the anti·· fl 
. - 1.n armnatory activity of these 
dialysable molecules and would 1 
comp ement the work of Billingham. 
Gordon and Robinson (1971) who found t hat livers from injured rats 
synthesized an anti-inflammatory Pr:<>tein when perfused with normal 
bl ood. These workEr's established that act inmnycin D which prevents 
protein synthesis, prevented the formati on of t he anti-inflammatory 
protein found in sponge exudate. 
Sponge induced inflammatory exudate both, contains 
oli goamines and is capable of releasing t hem when incubated in 
di alysis sacs. This fact offers another possible mode of action of 
spo.nge exudate. The oligoamines have been shown to be anti -
i nflammatory and are present in similar amounts in sponge exudate . 
t hus the anti-inflammatory effects of the exudate may be due , at 
l east in part, to the oligoamines. In addition , t he r elease of 
oli goamines by the exudate offers an explanation of t he anti-
i nflammatory effects of the dialysate. 
4. 8 · Conclusions 
The discovery that oligoamines have a di r ect anti-
inflammatory action may be important in several areas of study . 
In this work it has been shown that an anti - inflammatory 
exudate both contains and is capable of releasing oligoamines in 
amounts which would be pharmacological ly active . Although the mode 
. . is unknown it is obviously worthy of of action of the ol1.goam1.nes 
and a possibl e l ink with the cyclic AMP and further investigation 
does not appear unlikely . prostaglandin systems 
f liver damage and the resultant tissue The role o . 
1 been clarified since this 
l.·n i'nflammation has a so regeneration 
. ~hich has been shown to be 
involves the production of putresc1.ne 
anti-inflammatory. 
not e t hat treannent with It is interesting to 
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the hepatotoxin carbon tetrachlo~ide causes a conversion of spermid·n 
t o putrescine, the more potent anti-inflamnatory agent . 
Drug action, especially that of the steroidal drugs , 
may also be explained since steroids are known t o cause an increase 
in ODC activity and thus putrescine l evels . A possible reason for 
thi s effect may be offered by the work of Pitt and Lewis (1979) who 
suggested that steroidal drugs caused slight liver damage which 
would elevate ODC and putrescine levels. 
In conclusion oligoamines 1T1ay be very i mportant to our 
understanding of the basic mechanisms of i nflammat i on and also the 
development of new types of drugs may be possible . 
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